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 Cardiovascular function is under the influence of autonomic nervous system, both of 
which can be assessed non-invasively.  The purpose of this dissertation was to examine these 
non-invasive markers of cardiovascular and autonomic function and their relationships with 
exercise training, glucose ingestion and hydration status.  A series of three studies were 
conducted to gain insight to various influences on cardiovascular and autonomic function. 
 The first study examined the influence of exercise training of brachial artery flow-
mediated dilation (BAFMD) using meta-analytic techniques.  Sixty-six studies included in 
the analysis demonstrated exercise training improves BAFMD compared to controls.  Results 
indicated exercise training significantly alters BAFMD, a well-known factor associated with 
prevention of cardiovascular diseases.  Exercise training interventions including greater 
intensity and duration may optimize increases in BAFMD. 
 The second study observed glucose ingestion alters autonomic nervous system 
function, shifting the sympathetic/parasympathetic balance to higher sympathetic activity.  
Higher exercise intensity decreased fasting heart rate variability 24-hrs after cessation of 
exercise whereas lower exercise intensity did not alter heart rate variability.  Acute exercise 
increased heart rate variability after an oral glucose tolerance test, but was not affected by 
exercise intensity.   
 The last study determined the effect of chronic dehydration on cardiovascular and 
sweat responses during exercise in a heated environment.  Dehydration altered blood and 
urine markers of hydration status, and cardiovascular response to exercise in the heat.  In 
addition, BAFMD was related to the change in weighted skin temperature and body 
temperature during exercise in the heat, and increased LF/HF at rest was associated with 
#!"
increased peak heat storage.  Together these data suggest resting cardiovascular health may 




CHAPTER 1. INTRODUCTION 
 The cardiovascular system is adaptive and dynamic, constantly monitored by a 
number of mechanisms to provide precise alterations under various physiological conditions.  
The autonomic nervous system provides dual innervation to the cardiovascular system where 
it has short- and long-term effects.  Each beat-to-beat of the heart provides a circulatory 
pattern, or arterial pressure, which is subject to neural control via sympathetic and 
parasympathetic nerves.  A high beat-to-beat variability, or heart rate variability (HRV), is 
telling of a healthy heart.  Alterations in HRV can be utilized to assess autonomic imbalance 
in healthy and diseased states.  Kleiger et al. (1987) was a landmark study demonstrating 
decreased parasympathetic tone, measured by HRV, independently predicts mortality in post-
myocardial infarction patients1.  Several large epidemiological studies including the 
Framingham Heart Study and Atherosclerosis Risk in Communities (ARIC) Study, have 
since supported reduced parasympathetic activity, measured by HRV, to be associated with 
mortality in high and low risk cardiovascular disease (CVD) populations2,3.  In addition to 
HRV, endothelial function, measured by brachial artery flow-mediated dilation (BAFMD), 
has been linked to CVD as an independent predictor of future CVD events4,5.  The 
endothelial lining of blood vessels is innervated via the sympathetic nervous system, 
physically and physiologically connecting the cardiovascular and autonomic nervous 
systems.  Therefore, it is feasible autonomic imbalance and endothelial dysfunction are 
involved in the development of CVD. 
 Strategies of CVD management include surgical and pharmacological interventions, 
usually in the form of vasodilator medications6, leaving disparities in other treatment 
strategies including physical activity.  The relevance of exercise to the structure and function 
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of the cardiovascular system to cardiovascular health has been substantiated in both healthy 
and diseased patients7.  A sedentary lifestyle, one of the six major risk factors along with 
dyslipidemia, diabetes, hypertension, obesity and smoking, can be combated with increased 
physical activity, exercise and reduced sedentary time thereby reducing the likelihood of 
adverse cardiovascular events8,9. Recent popularity in non-invasive measurements of 
cardiovascular and autonomic function has yielded insights into the impact exercise training 
on the intertwined systems.  The non-invasive techniques utilized in this dissertation include 
brachial artery flow-mediated dilation (BAFMD), pulse wave velocity (PWV) and heart rate 
variability (HRV), which assess vascular function, arterial stiffness and autonomic balance, 
respectively. 
 The purpose of this dissertation was to study non-invasive markers of cardiovascular 
and autonomic function in response various conditions including exercise, glucose ingestion 
and dehydration.  Chapter 2 is an extensive review of scientific literature pertaining to 
cardiovascular and autonomic assessment and control during exercise.  In the following 
chapters (3-5), novel research addressed the following questions: 1) BAFMD and exercise 
training, 2) heart rate variability responses to glucose ingestion, and 3) cardiac and vascular 
function changes during exercise in the heat under hydrated and chronic, persistent 
dehydrated states.  Finally, Chapter 6 is a conclusion devised to summarize the findings 
outlined in this dissertation and provide future research directions.  
 The first project (Chapter 3) conducted was a meta-analysis examining the effects of 
exercise training on BAFMD.  To gain additional insight to potential modifiers of vascular 
function, meta-analytic techniques were applied to summarize and strengthen information on 
how exercise training impacts BAFMD.  We hypothesized that exercise training modified 
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BAFMD suggesting endothelial function can be improved with regular exercise.  In addition, 
this study also examined potential factors that moderate the impact of exercise training on 
BAFMD included disease status, fitness level and type, intensity and volume of exercise 
training. 
 Chapter 4 consisted of a crossover, counterbalanced study investigating the effect of 
glucose ingestion after acute exercise (at two different intensities) on HRV.  Following 
glucose ingestion, components of HRV have been shown to shift toward greater sympathetic 
tone in healthy and obese adults10,11.  Although exercise intensity is recognized as a factor 
affecting blood glucose, few studies have examined the impact of acute exercise at different 
intensities on HRV in response to glucose ingestion.  We hypothesized that a single bout of 
exercise would increase autonomic response to an OGTT and exercise intensity would 
mediate the response. 
 The final project (Chapter 5) sought to determine whether chronic hypohydration, 
achieved by fluid restriction over a 3-day period, alters cardiovascular function and sweat 
responsiveness during exercise in a heated environment compared to a euhydrated state.  In 
addition, this study assessed whether an individual’s resting cardiovascular function 
influences their cardiovascular, blood flow, and sweat responses to exercise in a heated 
environment.  Exercise in a heated environment has detrimental effects on cardiovascular 
function, core body temperature regulation and performance because of the increased 
demand for adequate sweat rate and heat dissipation through the skin12,13.  The combination 
of heat stress and dehydration may have an additive negative consequence on cardiovascular 
function and sweat responses14,15.  We hypothesized that (1) cardiovascular function and 
sweat responsiveness will be greater in the euhydrated state compared with the dehydrated 
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state during exercise in a heated environment due to less cardiovascular strain and heat stress 
during exercise; (2) resting cardiovascular profiles evaluated by PWV, BAFMD and HRV 
will influence cardiovascular function and sweat responsiveness more after chronic, 
progressive dehydration.   
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CHAPTER 2. LITERATURE REVIEW 
2.1 Introduction 
 According to the Centers for Disease Control and Prevention 2010 update, diseases of 
the heart are the primary cause of mortality in the United States, accounting for 24.2% of 
total deaths1,2.  Cardiovascular disease (CVD) is an extensive public health issue with a 
heavy economic cost in the United States estimated at ~$315 billion spent on associated 
health care3.  Additionally, racial and sex differences prevail in CVD and the associated risk 
factors, particularly among African-Americans4.  The inequalities and burden of CVD 
explains the rapid expansion of clinical and scholarly interest focused on the etiology, 
treatment and management of health outcomes related to CVD and associated CVD risk 
factors.  Popular strategies of CVD management include surgical and pharmacological, 
usually in the form of vasodilator medications3, leaving disparities in other treatment 
strategies including physical activity.  The relevance of exercise to the structure and function 
of the cardiovascular system has been substantiated in both overtly healthy and diseased 
patients5.  A sedentary lifestyle, one of the five major risk factors along with dyslipidemia, 
hypertension, obesity and smoking, can be combated with increased physical activity and 
exercise and reduced sedentary time thereby reducing the likelihood of adverse 
cardiovascular events6,7. 
 The cardiovascular system is adaptive and dynamic, constantly being monitored by a 
number of mechanisms to provide precise alterations under various physiological conditions.  
The heart, vast network of blood vessels, and contents of fluid (blood) that compose the 
cardiovascular system serve the following functions: (1) transport oxygen, nutrients and 
hormones to cells; (2) remove metabolic waste; and (3) regulate core temperature, pH and 
fluid balance8.  Blood pumped from the heart is transported through the two closed circuits 
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(pulmonary and systemic) of vasculature9.  During exercise, the vasoconstrictive and 
vasodilatory responses of the blood vessels direct blood flow to the active tissues though 
autonomic and vasoactive regulation.  The autonomic nervous system provides dual 
innervation to the cardiovascular system where it has short- and long-term effects.  Each 
beat-to-beat of the heart provides a circulatory pattern, or arterial pressure, which is subject 
to neural control via sympathetic and parasympathetic nerves.  A high beat-to-beat 
variability, or heart rate variability, is telling of a healthy heart.  
Several cardiovascular and metabolic diseases manifest in the vasculature.  Therefore, 
examining the association between both autonomic and vascular regulation, especially as 
they relate to physical activity and exercise, is warranted.  However, few studies have 
examined the relationship between autonomic and cardiovascular function in relation to 
demographic differences.  Although African-Americans have been reported to have 
differences in autonomic and vascular function compared to Caucasians10-12, the mechanisms 
behind these differences are poorly understood.  Therefore, the purpose of this review is to 
identify and describe structural and physiological features and techniques used in the 
measurement of the autonomic nervous and cardiovascular systems.  Furthermore, this 
review will describe the impact of race on the autonomic nervous and vascular systems as 
well as their responses to exercise. 
2.2 Cardiovascular Anatomy and Physiology 
 The cardiovascular system is responsible for bringing low-pressure venous blood to 
the heart, oxygenating blood through the pulmonary circuit and ejecting high-pressure 
arterial blood into the systemic circuit.  This closed circuit ensures the circulation and 
distribution of blood flow, and is necessary for achieving and maintaining homeostasis under 
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various conditions such as exercise.  The structure and function of the vascular network 
changes as blood travels away from the heart down the vascular tree.  In this section, I will 
describe the cardiovascular anatomy and the autonomic nervous system innervation of the 
cardiovascular system. 
 2.2.1 The Heart  
The heart is a four-chambered organ which pumps de-oxygenated blood to the lungs 
(pulmonary circulation) and oxygenated blood the rest of the body (systemic circulation).  
The two smaller, upper chambers of the heart are the atria while the two larger, lower 
chambers of the heart are called ventricles.  In general, the left ventricle has a thicker muscle 
(myocardium) and is capable of generating enough force to deliver blood to the entire 
systemic circuit.  The tricuspid and mitral valves separate the atria from the ventricles while 
the pulmonary and aortic valves separate the ventricles from pulmonary and systemic 
circuits, respectively.  The valves function to ensure unidirectional flow of blood through the 
heart.  The myocardium is composed of cardiomyocytes and intercalated discs giving the 
heart its myogenic property.  Meaning, the atria and ventricles act as separate syncytium in 
which nervous impulses spread rapidly through intercalated discs to allow the atria to 
contract separately from the ventricles.   
The rhythmic contraction-relaxation process of the heart’s chambers is called the 
cardiac cycle.  The rest, diastole or relaxation phase of the cardiac cycle is approximately 0.5 
seconds and allows for the heart to fill and receive its own blood supply via the coronary 
arteries.  The contraction or systole phase of the cardiac cycle is approximately 0.3 seconds 
and will eject an amount of blood (stroke volume).  In the first phase of the cardiac cycle, 
blood passively flows into the atria.  When the atria contract and atrial pressure increases, the 
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atrioventricular (tricuspid and mitral valves) open causing blood to flow into the ventricles.  
As atrial contraction completes, atrial pressure begins to fall causing the atrioventricular 
valves to close.  Following atrial systole, there is a period of time in which no blood flow is 
occurring and the ventricles are contracting (isovolumetric contraction).  Once the pressure in 
the ventricles exceeds the pressure in the arterial branches, the semilunar valves open and 
blood ejected.  After reaching a peak, ventricular pressure gradually declines causing 
semilunar valves to close and intraventricular pressure to continue to decrease as the 
ventricles relax (isovolumetric relaxation).  Lastly, once ventricular pressure drops below the 
pressure in atria, atrioventricular valves open, thus beginning the cycle again.  Given the 
heart has approximately one cardiac cycle per second, a healthy individuals heart rate is 60-
80 beat per minute8.  
Heart rhythm requires the synchronized contraction of all myocardium, which is 
initiated by electrical impulses originating at the sinoatrial (SA) node.  The SA node located 
in the right atrium serves as the physiological pacemaker and is regulated through autonomic 
innervation and hormones.  Sinoatrial (SA) node electrical impulses cause atrial 
depolarization (atrial contraction), and propagate to the atrioventricular (AV) node located in 
the interatrial septum where the signal slows briefly to allow for ventricular filling.  From the 
AV node, electrical impulses rapidly pass through the bundle of His, left and right bundle 
branches and purkinjie fibers to cause ventricular depolarization (ventricular contraction).  
The heart’s electrical activity can be detected using an electrocardiogram (ECG).  
 2.2.2 The Autonomic Nervous System 
The heart’s involuntary contraction is under the control of the autonomic nervous 
system (ANS).  The ANS is the motor division of the peripheral nervous system that is 
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essential to homeostatic functions (i.e. heart, lung, and digestive function, blood pressure).  
The ANS can be further broken into a parasympathetic and sympathetic nervous systems 
(PNS and SNS).  Parasympathetic and sympathetic neural outflow is primarily regulated by 
the medulla oblongata located in the brainstem that receives input from a wide range of 
higher centers including the cerebral cortex and hypothalamus13.  Within the medulla 
oblongata lie several integrative cardiovascular centers including the nucleus tractus 
solitarius (NTS), where sensory input from baroreceptors and peripheral chemoreceptors is 
received.  The neural mechanism most known for the short-term, tight control of blood 
pressure is called the baroreflex, which will be discussed in future sections14.   
The parasympathetic (“rest and digest”) and sympathetic (“fight or flight”) divisions 
are often antagonistic, but together they create a balance or tone.  The preganglionic nerves 
of the parasympathetic (craniosacral) division arise from the brain stem, or cranial, and sacral 
segments of the spinal cord.  The axons of preganglionic nerves that exit the central nervous 
system are long, with ganglia in or near the target organ.  The specific preganglionic neurons 
with parasympathetic activity are carried through cranial nerves.  The occulomotor nerve 
(III) innervates the pupil and levator palpebrae superioris muscle; the facial nerve (VII) 
innervates muscles of facial expression as well as two-thirds of the tongue; the 
glossopharyngeal nerve (IX) innervates the tongue and pharynx; and the vagus nerve (X) 
innervates the viscera of the thoracic and upper abdominal cavity.  The majority of 
parasympathetic neural outflow is carried through the vagus nerve.  Preganglionic neurons 
from sacral segments S2-S4 join the pelvic nerves to innervate viscera of the pelvic cavity.  
Within the ganglion both PNS and SNS preganglionic neurons release acetylcholine 
(cholinergic) at the synapse with the postganglionic neuron.  Postganglionic neurons of the 
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PNS are short in length due to their proximity to the effector tissues and primarily release 
acetylcholine.   
Preganglionic neurons of the sympathetic (thoracolumbar) division arise from the 
thoracic and lumbar (T1-L2) segments of the spinal cord, which travel through both pairs of 
spinal nerves.  Most of these axons are short reaching and synapse at the ganglia of the 
paravertebral sympathetic chain.  The sympathetic chain consists of 22 ganglions on either 
side of the spinal cord.  Postganglionic neurons may synapse with a postganglionic neuron at 
the level they exit from the central nervous system, travel up or down in the sympathetic 
chain to other ganglia, or may even synapse with more than one postganglionic neuron.  
Other preganglionic neurons pass through the chain to sympathetic collateral ganglia located 
halfway between the central nervous system and the target tissue.  Preganglionic neurons 
may also synapse within the adrenal medulla where modified postganglionic neurons secrete 
catecholamines (norepinephrine and epinephrine) into the bloodstream for longer lasting 
effects.  Axons of the postganglionic neurons synapsing at the sympathetic chain are long 
reaching and release norepinephrine (adrenergic) at the effector site. 
 Catecholamines and acetylcholine released from postganglionic neurons stimulate or 
inhibit activity of an innervated tissue depending on the receptors located at the target.  
Acetylcholine will bind to nicotinic or muscarinic receptors.  Muscarinic receptors are slow 
to alter metabolic activity because they are linked to second messenger systems15.  Of the 
five subtypes of muscarinic receptors (M1-M5) M1, M3 and M5 activation leads to increased 
intracellular calcium while M2 and M4 activation inhibits the second messenger cascade.  
Nicotinic receptor activation rapidly increases cellular permeability of sodium and calcium, 
which excites and depolarizes the specific tissue.  Catecholamines bind to either alpha (!) or 
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beta (") classes of adrenergic receptors.  Adrenergic receptors work through second 
messenger systems and the response depends on the subtype of the receptor.  Activation of !1 
receptors causes smooth muscle contraction; !2 inhibits insulin and induces glucagon; "1 
causes increased heart rate and contractility; "2 causes smooth muscle relaxation; and "3 
enhances lipolysis.  
 The ANS innervates both the heart and blood vessels.  Heart rate is controlled by the 
SA node and is under the “tonic” influence of both the PNS and SNS.  At rest the 
parasympathetic (vagal) tone dominates16.  Muscarinic-2 (M2) receptors on the SA and AV 
nodes are stimulated by release of acetylcholine from postganglionic fibers.  Activation of 
M2 receptors causes inhibition of the second messenger cAMP, leading to less cellular 
permeability to calcium.  This slows the speed of depolarization thereby decreasing heart 
rate14.  Conversely, the SNS has an excitatory effect on the heart due to postganglionic fibers 
releasing norepinephrine at postsynaptic terminals within the heart.  Norepinephrine targets 
"1 receptors located on the SA and AV nodes14.  Increased permeability to sodium increases 
the rate of depolarization leading to an increase in heart rate.  Bristow et al. demonstrated 
failing human hearts have a reduction in "1 receptor density and therefore increased tolerance 
to higher rates of sympathetic activity17.  Excessive sympathetic activity associated with 
heart failure promotes an increased concentration of norepinephrine.  Elevated 
norepinephrine concentrations predict heart failure survival independent of the severity of 
heart failure18. 
 Smooth muscle of blood vessels are sympathetically innervated and lack 
parasympathetic innervation, giving blood vessels a constant, partial vasoconstriction due to 
the discharge of sympathetic activity19.  The vasoconstriction can be illustrated by 
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interruption of sympathetic tone with an !-adrenergic agent resulting in an increase of blood 
flow to skeletal muscle20.  However, the endothelium of blood vessels appears to have 
parasympathetic cholinergic innervation.  M3 receptors located on the vascular endothelium 
are involved with the production of nitric oxide, a potent vasodilator.  Blockage of nitric 
oxide production leads to M2 and M3 receptors causing vasoconstriction.  The latter finding 
may be suggestive of vascular dysfunction where nitric oxide production is impaired.  
Similarly, removal of the vascular endothelium in rabbit carotid arteries increased the release 
of norepinephrine from sympathetic nerves, suggesting vascular function is important to 
ANS regulation21.  
 2.2.3 General Vascular Wall Structure 
The general wall arrangements of an artery and vein are depicted in Figure 2.1.  The 
vascular system in generally divided into five classes of vessels including arteries, arterioles, 
capillaries, venules and veins.  The extensive vascular network has a wall structure composed 
of three histological layers: the internal endothelial coat or tunica intima; the middle 
muscular layer or tunica media; and external connective tissue coat or tunica adventitia9.  
With the exception of the capillaries, which are solely an endothelium layer, each class of 
vessel has a variation of the three layers forming its wall.  The tunica intima is the innermost 
layer formed by a single celled lining of endothelium mounted on a fenestrated elastic 
membrane9. Beneath this membrane lies a sub endothelial layer of connective tissue.  The 
relationship of the tunica intima to the tunica media is of particular importance because it not 
only provides a physical barrier between the tunica media and the contents of the lumen, but 
also facilitates actions of the tunica media.  Tunica media is the middle layer comprised of 
smooth muscle cells in a concentric framework of elastic sheets, collagenous fibers, and 
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elastic fibrils22.  Actions of the tunica media include acute changes in diameter in response to 
mechanical or neuro-hormonal mechanisms as well as strengthen the vessel wall to protect 
against blood pressure forces.  Finally, the outermost layer, tunica adventitia (externa), is a 
dense fibro-elastic sheath surrounding the vessel.  Chiefly comprised of collagen fibers, the 
tunica adventitia blends with adjacent tissues to anchor and stabilize the vessel and protect 
the vessel under high pressure22. 
 
Figure 2.1. Comparison of wall structure of blood vessels.  Taken with permission from23. 
 
Extending into the lumen from the endothelium is a hair-like layer termed endothelial 
glycocalyx.  Endothelial glycocalyx, also known as the endothelial surface layer (ESL), is 
connected to the endothelium through several negatively charged “backbone” molecules, 
mainly proteoglycans and also glycoproteins24.  The thickness of this layer increases as 
vascular diameter increases25 and is subject to a balance of biosynthesis and shedding26.  
Endothelial glycocalyx functions as a permeable “gatekeeper” to the endothelium by 
mediating the access of certain molecules and interacting in leukocyte and thrombocyte 
adhesion.  The vasoprotective properties of the endothelial glycocalyx make it an anatomical 




2.2.4 Arterial System 
Arteries, or efferent vessels, distribute blood throughout the body and decrease in size 
as they move away from the heart.  The arterial system (arteries and arterioles) is subjected to 
high pressure, which is why arteries are classified as elastic, or conducting vessels16. Arteries 
are the largest in diameter and allow for stretch with each cardiac cycle without collapsing 
due to a high ratio of elastic fibers to smooth muscle fibers and thick intima layer22.  The 
aorta (~2.5cm) is a major elastic artery of the body that receives the volume and pressure 
load from the left ventricle and supplies all of the systemic circulation.  
 Arteries subdivide into arterioles, such as the brachial or popliteal arteries, and are 
classified as muscular arteries.  These muscular, or conduit arteries, are responsible for 
carrying blood to major regional vascular beds.  Though arterioles have poorly delineated 
layers within the tunica adventitia and a multi-layer, concentric tunica media16,22, they have 
the greatest influence on peripheral pressure and blood volume distribution.  Due to the 
relatively thicker layer of smooth muscle fibers, the ability to regulate vessel diameter allows 
arterioles to control blood flow.  Arterioles progressively divide in to smaller branches 
considered terminal arterioles where the internal elastic lamina disappears and smooth 
muscle fibers become continuous, leaving solely the tunica interna16.  
Capillaries are the smallest diameter blood vessels that arise from arterioles, but have 
the largest cross-sectional area in the vascular network.  The capillary wall is composed of 
only the intima layer of endothelium and a thin basement membrane with occasional gaps, 
and terminate in networks of vessels that pervade every tissue in the body9.  The capillary 
diameter (~8µm) is typically wide enough for the passage of a single column of erythrocytes, 
which allows the exchange of gases and nutrients to occur quickly.  Capillaries are classified 
"
 16 
according to their structure as continuous, fenestrated or sinusoidal (discontinuous).  
Continuous capillaries are abundant in skin and muscle and have a complete lining of 
endothelium with tight junctions16.  Fenestrated capillaries have pores due to an incomplete 
lining of endothelium to allow greater permeability in glandular, intestinal and kidney tissue.  
Lastly, sinusoidal or discontinuous capillaries located in organs including the heart, liver and 
spleen and are in direct contact with the cells of the organ9.  
Two categories of capillary beds exist.  First, several arterioles directly form 
thoroughfare channels, which are an intermediate between arterioles and venules16.  The 
meta-arteriole contains smooth muscle cells and is responsible for the delivery of blood into 
capillary beds.  Secondly, true capillaries stem from the meta-arteriole and provide gas and 
nutrient exchange.  Typically, a band of smooth muscle (pre-capillary sphincter) surrounds 
the root of each true capillary at the thoroughfare channel to regulate blood flow into the 
capillary bed.  Depending on the need for blood supply at the local level, pre-capillary 
sphincters can open (sensing oxygen, carbon dioxide, blood pH levels) for blood to flow to 
the tissues or close for blood to be shunted through the channel. 
2.2.5 Venous System 
 Venules and veins collect the blood from the capillary beds and serve as and serve as 
a low-pressure reservoir under rested conditions eventually returning blood to the heart.  The 
venous system differs from the arterial system in that the tunica media is much less 
developed allowing for veins to collapse9.  The collapsibility of the vessel is advantageous 
when muscle tissue contracting around venous walls is able to compress the veins and aid in 
return of blood to the heart.  This mechanism called the ‘muscle pump’ will be discussed in 
further detail in latter sections.  Connecting the arterial and venous side are post-capillary 
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venules.  Venules have a small number of smooth muscle cells and eventually pour into 
collecting venules and in turn small collecting veins16.  Veins carry blood from venules to the 
large veins and ultimately the heart. Due to their large lumen that can collapse and expand as 
well as the low pressure of venous system, veins can be considered capacitance vessels 
where 60-80% of the total blood volume lies at rest8.  Finally, large veins specifically return 
blood to the heart (i.e. superior and inferior vena cava). 
 A second marked difference between arteries and veins is the presence of one-way 
valves.  Formed by a invagination of tunica intima and reinforced with connective tissue and 
elastic fibers9, one-way valves are located in the lumen to prevent the back-flow of blood 
away from the heart.  These valves play a role in postural transitions, particularly when 
moving from supine to upright, blood pooling in the periphery is prevented28. 
2.3 Autonomic and Vascular Assessments 
 With an appreciation of cardiovascular structure and function, it is appropriate to 
methodologically quantify cardiovascular physiology.  Although there are several techniques 
applicable to the field of autonomic and cardiovascular assessment, the non-invasive tools 
related to this specific review will be discussed.  
 2.3.1 Autonomic Function Assessments 
 Historically, the variation in the beat-to-beat time length during the respiratory cycle 
was first observed in horses by Stephen Hales in 1733; however, Carl Ludwig was the first to 
be accredited for the report of cardiac variability in humans29.  Heart rate variability (HRV) is 
defined as the degree of fluctuation in the length of intervals between heart beats30.  A 
number of techniques for the assessment of cardiovascular autonomic control have been 
developed to quantify the heart rate variability31.  The assessment of HRV requires acquiring 
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either a long-term (24-hour) or short-term (5-minute) ECG whose signal is converted to a 
tachogram.  This simple method of HRV detection identifies variations in time intervals 
between QRS complexes of an ECG, which can be called R-R or N-N (normal-to-normal) 
intervals.  During inspiration, parasympathetic activity is inhibited by the inflation of the 
lungs, causing an increase in heart rate.  During expiration, the parasympathetic activity is 
stimulated to slow heart rate.  Thus, N-N intervals have different lengths depending on the 
point in the respiration cycle.  The two most common techniques for measuring HRV are 
time and frequency domain measurements.  Table 2.1 describes the commonly used 
parameters used to measure HRV. 
Table 2.1. Frequently used HRV parameters for autonomic assessment. 
Variable Units Description 
Time Domain Measurements 
Mean RR ms Average of all RR (NN) intervals 
SDNN ms Standard deviation of RR (NN) intervals 
RMSSD ms Square root of the mean of the sum of squares of differences between adjacent RR (NN) intervals 
NN50 count Number of RR (NN) intervals >50ms apart 
pNN50 % NN50/Total RR (NN) intervals x100; Percent of adjacent RR (NN) intervals >50ms apart 
Frequency Domain Measurements 
VLF ms2 Very Low Frequency  (0.0-0.04Hz) 
LF ms2 Low Frequency (0.04-0.15Hz); represents mixed sympathetic and parasympathetic activity 
HF ms2 High frequency (0.15-0.40Hz); represents parasympathetic activity 
LF/HF Ratio - Ratio of sympathetic and parasympathetic activity; represents autonomic balance 
Total power ms2 Total variance of RR (NN) intervals; represents total HRV 
ms=milliseconds; %=percent 
 Time domain analysis is used to evaluate heart rate fluctuation as a function of time.  
The standard deviation of the N-N interval (SDNN) is one of the most widely used time 
domain indices of HRV32.  The SDNN (milliseconds) value depends on the length of the 
recording (i.e. the longer the recording, the lower SDNN value)33.  SDNN reflects all factors 
that contribute to HRV.  A lower SDNN would indicate lower variability and greater 
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sympathetic activity, and conversely a higher SDNN would indicate greater variability and 
greater parasympathetic activity.  The square root of the mean squared differences of 
successive N-N intervals called the RMSSD (milliseconds) can be calculated.  The RMSSD 
is an estimate of short-term variation and provides information regarding vagal activity of the 
heart. The percent of adjacent N-N intervals less than 50ms apart (pNN50 (%)) is a function 
is virtually independent of circadian rhythms and reflects vagal-mediated alterations in 
autonomic function.  Time domain analyses may be simple to calculate, but do not quantify 
autonomic balance between the SNS and PNS because they are of first order statistics30.  
SDNN is a function of heart rate behavior over time and gives long-term information that is 
sensitive circadian rhythms.  RMSSD and pNN50 are parameters based on interval 
differences that are not sensitive to diurnal variation and reflect short-term beat-to-beat 
variation that is caused by vagal-mediated parasympathetic activity31. 
 Frequency domain analysis, also called power spectral analysis, reflects the amplitude 
of the heart fluctuations at different frequencies31.  The NN intervals can be decomposed into 
different frequency bands depending on the autonomic activity.  Lower frequency bands are 
associated with sympathetic activity and higher frequency bands are corresponding to 
parasympathetic activity34.  Very low frequency (VLF) domains are frequency bands 
between 0.003-0.04Hz, which generally indicate the activity of slow mechanisms controlling 
sympathetic function.  Low frequency (LF) domains are also indicators of sympathetic 
activity and range from 0.04-0.15Hz.  However, LF domains can reflect parasympathetic 
activity as well, especially when an individual’s respiration is extremely low, for instance, 
during sleep.  High frequency (HF) bands range from 0.15-0.40Hz.  HF domains are also 
called the “respiratory” band because they correspond with NN variations caused by 
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respiration.  HF domains represent a measure of parasympathetic activity and are generally 
associated with HRV (increased HF, increased HRV).  The LF/HF Ratio is a measure of the 
sympathovagal balance.  A high ratio would reflect sympathetic dominance and conversely a 
low ratio would suggest parasympathetic dominance.  
Testing baroreflex sensitivity has also been used as a simple method to examine 
autonomic cardiovascular control.  As stated previously, the baroreflex is the neural 
mechanism required for short-term control of blood pressure.  Baroreceptors, also known as 
mechanoreceptors, are stretch receptors located in the carotid sinus and aortic arch that are 
sensitive to changes in intravascular pressure.  Presumed inactive at pressures lower than 
60mmHg, baroreceptors increase the rate of firing when pressures reach 60-180mmHg and 
90-210mmHg in the carotid arteries and aorta, respectively14.  For example, the baroreceptors 
sensing an increase in pressure would stimulate nerve propagations to the NTS, inhibiting the 
vasoconstrictor center and exciting the parasympathetic center.  In turn, this would reduce the 
heart rate and myocardial contractility leading to a drop in blood pressure.  
Assessing the baroreflex can be done invasively with intravenous vasoactive drugs, 
but also non-invasively through the Valsalva maneuver.  Baroreflex sensitivity can be 
quantified as the time lag between systolic pressure and NN intervals (ms/mmHg)35. To 
perform the maneuver, forced expiration forces the glottis closed which transiently elevates 
the intrathoracic pressure.  Initially, the increase in pressure deactivates baroreceptors that 
then trigger vasoconstriction and increases heart rate.  Immediately following the maneuver, 




The response time of the PNS and SNS differ greatly due to their efferent pathways.  
Typically, the parasympathetic activation is an immediate response while sympathetic 
activation can take 2-3 seconds.  Therefore, the ability of the baroreflex to control beat-to-
beat regulation is done through vagal activity35.  Cardiovascular diseases such as 
hypertension, myocardial infarction and heart failure are associated with increased 
sympathetic activity and impaired baroreflex mechanisms36,37. 
2.3.2 Conduit Vessel Assessments 
A widely accepted non-invasive method to assess macro-vascular function is Doppler 
Ultrasonography.  In the 1990’s, Doppler Ultrasonography was employed to provide 
structural and functional information for large conduit arteries (i.e. brachial or popliteal 
artery) as well as blood flow and velocity.  A pulsed ultrasound wave is emitted through a 
target tissue and a returning ‘echo’ is briefly detected by a crystalized probed, called a time 
gate.  Depending on the length of time between signal emissions and returning activation, the 
depth of the targeted structure can be estimated38. This gives a three dimensional map of the 
vessel.  The frequency of reflected ultrasound waves corresponds the blood flow velocity39.  
This can be visualized in real time (duplex mode), which allows for blood flow velocity and 
direction determination. 
Doppler ultrasound had been employed to examine responses to a physical stimulus.  
Initially, Celermajer and colleagues (1992)40 developed a protocol using the brachial artery 
since it could easily be imaged by ultrasound.  After acquiring a resting image of the brachial 
artery a period of forearm occlusion was used to create a shear stress.  The percent change in 
vessel diameter after forearm occlusion (termed flow-mediated dilation; FMD) is used as a 
marker of vascular function and is also thought to be a potential marker for coronary artery 
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disease41.  Several factors have been known to influence vaso-reactvitiy including subject 
preparation, time of day, meal composition, smoking and exercise.  Therefore, technical 
guidelines have provided a more universal approach to minimize biological and 
environmental variability41-43.  The measurement of flow-mediated dilation (FMD) has been 
shown reproducible and accurate under these standardized conditions44,45.  Furthermore, 
FMD is predictive of future cardiovascular events in healthy46 and diseased47 populations. 
 2.3.3 Resistance Vessel Assessments 
 The systemic vasculature has mechanical properties important to the cardiac work of 
the heart. Hence arterial distensibility and compliance have been targeted has potential 
indicators of cardiovascular health.  The non-invasive method used to evaluate these 
characteristics in resistance arteries is applanation tonometry.  Using a hand-held strain 
gauge pressure sensor over the radial artery, the arterial pulse is digitally recorded.  From this 
recording, a series of algorithms generates pressure waveforms and provides central blood 
pressure, augmentation pressure and index.  The augmentation index is defined as the ratio of 
height of the peak above the shoulder of the wave to the pulse pressure, and indicates the 
pressure rise resulting from the peak flow input into the vasculature prior to wave 
reflection48.  An increase in the pulse pressure and augmentation index represents arterial 
waves reaching the heart during systole, which leads to an increase in cardiac afterload 
(forces opposing ejection of blood from the heart)49.  
 Another noninvasive measure that can be obtained from applanation tonometry is 
pulse wave velocity. Pulse wave velocity (PWV) is based on the pulse pressure generated by 
the ventricular ejection that travels through the vasculature at a certain speed.  Using the 
same strain gauge pressure sensor, arterial pulse waves are recorded at two different sites 
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along the vascular tree (i.e. carotid and radial arteries). The PWV is derived from foot-to-foot 
transit time and the distance between the two waves.  The distance from the carotid pulse to 
the suprasternal notch and from the suprasternal notch down to the radial artery are measured 
by gulick tape.  The speed at which this pulse travels is altered by the mechanical properties 
of the vessel giving a gauge of distensibility and compliance.  Higher PWV demonstrates a 
greater vascular resistance and rigidity of the vascular wall50.  The ease of this measurement 
and high reproducibility (0.14±0.829m/s within-observer and -0.44±1.09m/s between-
observer) 51 has allowed for applanation tonometry to be applied in clinical settings.  PWV is 
strongly associated with cardiovascular events and all-cause mortality52,53 in hypertensive 
patients53. 
2.4 Neural Cardiovascular Control during Dynamic Exercise 
 Exercise is defined as a structured form of physical activity aimed at improving or 
maintaining physical fitness6.  Cardiovascular responses to aerobic exercise are a result of 
central neural command and skeletal muscle mechanical stimuli.  Depending on the physical 
task presented to the body, the acute responses and chronic adaptation of the cardiovascular 
and nervous system vary in order to provide the most efficient response.  In this section, I 
will address cardiovascular and autonomic regulation at the onset of aerobic exercise and 
after chronic aerobic training. 
 2.4.1. Cardiac Performance 
The heart functions to maintain blood pressure, which is accomplished through 
alterations in cardiac output.  Cardiac output (Q), the product of heart rate and stroke volume, 
is the amount of blood pumped by the heart per minute (L/min).  Adjustments in either heart 
rate or stroke volume will influence cardiac output (Q).  Stroke volume during exercise is 
"
 24 
determined by the following factors: preload, afterload, myocardial contractility and heart 
rate8.  At the onset of exercise demand for oxygen to active tissues promoting a shift of 
oxygen offloading into the tissue.  In humans, the Fick equation explains the rate of oxygen 
uptake (VO2) from inspired air (Equation 4.1).  The amount of oxygen taken up (VO2) into 
the blood is the difference in the rate (Q) of the amount of oxygen leaving (oxygenated 
blood) and entering (deoxygenated blood) the lungs. Therefore, oxygen uptake (VO2) is the 
product of Q and arterial-venous oxygen concentration difference (a-vO2 diff). 
Equation 4.1 VO2 = Q * a-vO2 diff or VO2 = HR * SV * a-vO2 diff  
 Each component (HR, SV and a-vO2 diff) can increase VO2 during exercise.  The 
heart is under the influence of the autonomic nervous system that has the ability to increase 
HR, SA node firing rate and force of contraction.  At rest the parasympathetic nervous 
system dominates typically keeping HR at 60-80beats/min8.  The body is capable to 
overriding the PNS activity to the heart as seen with the anticipatory response prior to 
exercise.  The anticipatory response causes a rise in HR prior to or leading up to the start of 
exercise due to a release in epinephrine is not uncommon when individuals are put in a 
stressful environment such as competitions or exercise testing.  At the onset of exercise, HR 
increases due to the withdrawal of parasympathetic (vagal) tone and the increase in 
sympathetic activity54.  During submaximal aerobic exercise (~100-150beats/min), HR 
increases to raise cardiac output to meet the oxygen demand of the active muscle mass. At a 
low-to-moderate intensity, the rise in HR is predominately mediated by the withdrawal of 
parasympathetic activity8.  At approximately 50-60% of VO2max the increase in HR is a result 
of sympathetic activity55.  Steady state HR for a given workload can be achieved typically 
within 2 minutes, but will increase linearly as exercise intensity increases.  The point at 
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which heart rate begins to level off with an increase in intensity is indicative of maximal 
exercise capacity (~180-200bpm).  Immediately after the cessation of exercise, heart rate 
drops quickly (heart rate recovery) due to the rapid parasympathetic reactivation.  Individuals 
with higher levels of fitness have higher resting levels of parasympathetic activity leading to 
bradycardia, and therefore have lower resting HR and more rapid HR recovery compared to 
unfit individuals56.  Several pharmacological agents also influence heart rate.  For example, 
atropine is commonly used to block parasympathetic activity and increase heart rate, while 
propranolol selectively blocks sympathetic activity resulting in a decreased heart rate54. 
Stroke volume (SV) (~70mL) is the difference between left ventricular end-diastolic 
volume (~130mL) and left ventricular systolic volume (~60mL).  In an upright position, SV 
increases curvilinear with work rate during exercise to ~90mL, or about 50% of its maximum 
where reaches a plateau.  Preload, afterload, myocardial contractility and heart rate8 are each 
factors that influence SV.  The relationship between SV and preload (myocardial stretch) is 
described by the Frank-Starling mechanism.  Briefly, an increase in end-diastolic volume 
increases the preload, which stretches the ventricular muscle fibers.  This stretch leads to an 
increased force of contraction causing the heart to eject the larger volume of blood.  The 
extent of left ventricular preload is subject to several factors including the ventricular cavity 
size, total blood volume, venous tone, intrathoracic pressure, body position and the blood 
return to the heart due to the muscle pump.  During exercise in the upright position, preload 
is increased via an increase in venous return; venous constriction, the muscle pump and 
respiratory activity increasing and decreasing intrathoracic pressure to rhythmically move 
more blood to the heart (respiratory pump) to achieve a greater preload.  Conversely, venous 
return can be decreased by vena cava compression as seen during a Valsalva maneuver.  The 
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Valsalva maneuver raises intrathoracic pressure leading to a decreased transmural pressure 
(pressure across the wall of a blood vessel).  This pressure differential results in venous 
compression, which impedes venous return into the thorax and reduces preload.  Venous 
return is also sensitive to alterations in body posture in the absence of compensatory 
mechanisms.  In particular, standing body posture results in gravity driven pooling of blood 
in the lower extremities that reduces blood to the heart and preload.  Orthostatic intolerance 
encompasses several conditions where when standing the skeletal muscle pump mechanism 
is not activated to maintain venous return, sympathetic nerve activity becomes less effective 
in venous constriction and blood pools57.   
 The last component that influences VO2 is the a-vO2 diff, or the amount of oxygen 
extracted at the tissue level.  During exercise a-vO2 difference increases with an increase in 
exercise intensity from ~5mL O2/100mL blood to ~15mL/100mL blood at maximal exercise.  
The a-vO2 difference is dependent on the arterial oxygen carrying capacity, the ability of the 
respiratory system to load oxygen and the ability to unload oxygen in the active tissues.  
Trained individuals tend to have greater oxygen carrying capacity and a-vO2 difference than 
sedentary counterparts during maximal exercise.  No matter the exercise intensity, some 
oxygenated blood will supply other tissues that are not fully active8. 
2.4.2 Circulation 
 2.4.2.1 Principles of Blood Flow 
 The peripheral vascular network is responsible for the circulation of ~5 liters of 
blood.  Circulation through the different vascular compartments changes as each has different 
properties that manipulate hemodynamics, and therefore alters rate of blood flow to a specific 
region of the body.  Control of blood flow, or Q can be described in terms of principles of 
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fluid mechanics (flow, pressure and resistance) and the assumption that fluids are continuous.  
The driving force of blood flow is the pressure differences at two ends of a vessel, which is 
almost always along a gradient of high to low areas of pressures8.   The relationship of flow 
to pressure and resistance is described below, where Q is directly proportional to the change 
in pressure (#P) between two ends of a blood vessel and inversely related to the total 
peripheral resistance (TPR) (Equation 4.2). Total blood flow, expressed Q in liters per minute 
(L/min), is ~5L/min at rest and is capable of increasing five to six fold during exercise (25-
30L/min)8.  
Equation 4.2 Q = #P/TPR 
 The movement of blood at a steady rate through a vessel in concentric, streamline 
layers is called laminar flow58.   During laminar flow, the velocity in the center of the lumen 
is greater than that at the edges due to contact with the intima.  The drag of the outermost 
layer of blood causes the next layer slip by and so on forming a parabolic velocity profile 
where blood layers in the middle are able to move by rapidly.  In contrast to laminar flow is 
turbulent flow, which can occur as blood passes obstructions such as curvatures or 
bifurcations.  Turbulent flow is unparalleled, disorganized and creates detectable sounds 
(known as Korotkoff sounds)58.  The probability or tendency of turbulent blood flow can 
predicted by Reynold’s number (Re) which is directly proportional to the mean velocity of 
blood flow ($), vessel diameter (d), density of blood (%), and inversely proportional to the 
viscosity of the blood (&) (Equation 4.3).  When the value of Re is greater than 2000 
(unitless), turbulence is almost always present58.  For instance, an atherosclerotic plaque 
narrowing the artery would create high blood flow velocity through the point of constriction 
and loud, turbulent blood flow beyond that point. 
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Equation 4.3 Re = $d%/& 
Furthermore, this principle can be applied when the measuring blood pressure; the cuff 
narrows the artery creating turbulent flow identified as systolic pressure, and as flow 
becomes laminar the diastolic pressure can be determined.  In situations where the vessel is 
small and essentially no rapidly flowing center of blood exists, Poiseuille’s Law can be 
applied (Equation 4.4) where the rate of blood flow (Q) is directly proportional to the 
pressure change (#P) and radius (r4) and inversely related to viscosity (&) and length of the 
vessel (l).  Note that the radius of the blood vessel markedly affects blood flow (to the fourth 
power).  Hence arterioles, which are capable of precise diameter changes, have pronounced 
affects on the regulation of peripheral resistance and blood flow.  In equation 4.4, viscosity of 
blood is taken into account, but does not have a large affect on blood flow unless there is a 
considerable change in the hematocrit58 (i.e. blood doping or dehydration).  
Equation 4.4 Q = '#Pr4/8&l 
  2.4.2.2 Blood Flow Regulation 
 Local control of blood flow is mediated through multiple mechanisms to adjust blood 
flow to match metabolic demands while maintaining systemic and cerebral blood pressures. 
Transitioning from rest to exercise increases demand for skeletal muscle and skin blood flow 
and decreases demand for visceral blood flow.  This rapid shunting of blood from one system 
to another involves autoregulation and neural control via the sympathetic nervous system.  At 
rest, the sympathetic nerves that innervate arterioles exhibit a tonic discharge giving vessels a 
resting, constricted tone19.  During exercise, sympathetic outflow is increased causing 
vasoconstriction at inactive tissue mediated through !1 or !2 receptors and vasodilation 
mediated through "1, "2 or M3 receptors at active tissue.  However, sympathetic discharge 
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balances parasympathetic activity in exercising muscle even during high intensity exercise in 
order to maintain blood pressure59,60.  Buckwalter et al. (2001) found alpha-adrenergic 
receptor sensitivity of arterial vasculature in exercising muscle is attenuated from rest to 
exercise in an intensity-dependent manner, suggesting a decrease in the magnitude of 
vasoconstriction allowing for the active skeletal muscle to receive more blood flow61.  
Factors that affect sympathetic constriction of the arteries and arterioles include, but are not 
limited to, density of sympathetic nerves and subtype of adrenergic receptors, differences in 
norepinephrine kinetics, degree of resting tone, and concentration of metabolites from muscle 
activity19.  Although sympathetic nerves are active during exercise, NO released from the 
endothelium may blunt vascular response to sympathetic activity, a phenomenon called 
functional sympatholysis62.  Jendzjowsky et al. (2013) demonstrated NO inhibition 
augmented sympathetic vasoconstriction while NO blockade did not, suggesting a NO-
mediated mechanism is behind functional sympatholysis during rest and exercise63. 
Blood flow is coupled with metabolic regulation of peripheral tissues.  The formation 
of vasodilatory metabolites (potassium, magnesium, carbon dioxide, adenosine, hydrogen 
ions) and hormones (bradykinin, histamine) occurs when the metabolic rate of a specific 
tissue increases or oxygen delivery decreases14.  Under exercising conditions, metabolic 
factors are released from active muscle, diffuse through the interstitial space, and act on 
smooth muscle cells to increase blood flow.  Conversely, vasoconstricting metabolites 
(calcium, endothelin-A) and hormones (angiotensin II, vasopressin) may decrease blood 
flow.  Occluding a vessel can also interfere with blood flow to produce an increase in 
vasodilatory substances, called reactive hyperemia or hypoxia-induced vasodilation.  
Reduced oxygen supply (oxygen tension) and increased oxygen demand to active tissues 
"
 30 
creates a hypoxic environment.  Upon release of clamping a vessel blood flow increases 
above resting level and remains elevated until metabolic conditions return to homeostasis13.  
Local vasodilation in response to tissue hypoxia ensures oxygen delivery to metabolically 
stressed areas under normal conditions64. 
One of the most important local dilating factors is endothelial derived NO. Furchgott 
and Zawadski (1980) were the first to recognize the importance of the endothelium in 
controlling vascular smoother muscle tone65.  In rabbit arteries, disruption of the endothelium 
abolishes NO-mediating response of acetylcholine, suggesting the intact endothelium is 
necessary for vasodilation in response to acetylcholine.  Physical stimuli such as reactive 
hyperemia can lead to endothelium-dependent vasodilation.  For example, contracting 
skeletal muscles during exercise produce shear stress on a vessel, increasing calcium flux 
into the intracellular space through specific stretch activated calcium channels.  The rise in 
intracellular calcium triggers vascular smooth muscle relaxation through three pathways; 1) 
production of nitric oxide (NO) via nitric oxide synthase (eNOS), 2) production of 
prostacyclin (PGI-2) and 3) endothelium-derived hyperpolarizing factor (EDHF)66.  Figure 
2.2 is a model of receptor-signal transduction in endothelium cell which leads to 
vasodilation67.  Nitric oxide (NO) is produced from the metabolic conversion of L-arginine to 
L-citrulline via eNOS.  The NO formed in the endothelium diffuses to the smooth muscle 
cells, where it interacts with guanylate cyclase to produce cyclic guanosine monophosphate 
(cGMP)58.  The cGMP activates additional protein kinases, increasing calcium release and 




Figure 2.2. Production of nitric oxide (NO) by endothelial cells. NO is produced by the 
action of endothelial nitric oxide synthase (eNOS) on l-arginine. This reaction requires a 
number of cofactors, including tetrahydrobiopterin (BH4) and nicotinamide adenine 
dinucleotide phosphate (NADPH). Increased intercellular Ca++ in response to vasodilator 
agonists or shear stress displaces the inhibitor caveolin from calmodulin (CaM), activating 
eNOS. NO diffuses to vascular smooth muscle and causes relaxation by activating guanylate 
cyclase (GC), thereby increasing intracellular cyclic guanosine monophosphate (cGMP). 
Reprinted with permission from67. 
 
Myogenic regulation occurs in direct response to a rise or fall in blood pressure to 
maintain a vascular tone.  Under increasing transmural pressure vascular smooth muscle 
contracts, thus allowing for blood flow through a vessel to remain constant.  This inherent 
behavior is most pronounced in arterioles to protect against over-perfusion of capillaries.  
The stimulus for the myogenic action, or Bayliss effect, postulated to be triggered by an 
increase in wall tension from stretch in the blood vessel.  The distended vessel then opens 
stretch-activated ion channels to release calcium.  The influx of calcium leads to smooth 
muscle contraction and in turn reduces the radius of the vessel14. 
 2.4.3 Adaptations to Exercise Training 
 Considerable data demonstrates long-term (weeks to months) exercise training 
increases cardiorespiratory fitness, which is associated with lower heart rate, increased vagal 
tone and improved endothelial function.  Typically with 6-months of exercise training, a 15-
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20% increase in VO2max can be expected68. Previous cross-sectional studies suggest both 
young and older physically active participants have superior vascular and autonomic health 
compared to sedentary, inactive individuals69-73.  Furthermore, clinical patients with the 
highest CVD risk and lowest cardiorespiratory fitness who increase their levels of physical 
activity may have the greatest health benefits74.  Since exercise capacity has been strongly 
associated with cardiovascular events and all-cause mortality in patients with known 
CVD6,75, exercise training is imperative to developing positive cardiovascular adaptations 
that combat disease in both healthy and sick populations. 
 From the Fick equation, VO2max following exercise training is increased due to 
adaptations in HR, SV and a-vO2 diff.  At rest a trained individual has a lower resting and 
submaximal exercise HR compared to an untrained individual; however, at maximal exercise 
HR does not differ greatly.  Exercise training enhances parasympathetic modulation and 
decreases sympathetic activity at rest in healthy populations54,76, which may contribute to 
bradycardia.  Several cross-sectional studies comparing athletes to sedentary controls reflect 
an increase in HRV, particularly an increase in the high frequency domain (parasympathetic 
activity)77-79.  For example, long distance runners have demonstrated a lower resting HR, 
greater high frequency (parasympathetic activity) and reduced low frequency (sympathetic 
activity) compared to sedentary controls79.  Longitudinal exercise training studies in 
sedentary participants have also demonstrated an improvement in autonomic balance70,80.  
For example, Melanson et al. (2001) showed a 14% increase in VO2max and increase in 
pNN50, RMSSD and HF after 16 weeks of moderate exercise training70.    
 Stoke volume (SV) increases approximately 20% with exercise training, with the 
increases occurring at rest, during submaximal and maximal exercise8.  A trained individual’s 
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stroke volume may approach ~150-200 mL, compared to 110-130 mL in untrained people, 
which can potentially be attributed to increased blood volume and contractility.  A longer 
adaptive response includes hypertrophy of cardiac muscle fibers.  Higher Q values in trained 
individuals at maximal exercise are related to the increases in SV as opposed to changes in 
maximal a-vO2 diff.  The rate of blood flow and oxygen delivery to the tissue is higher, 
which may lead to the faster unloading of oxygen.  The slight adaptation in a-vO2 diff at rest 
and during submaximal and maximal exercise may have to do with oxygen’s affinity to 
hemoglobin.  With exercise training the blood may loosen the binding of oxygen to 
hemoglobin to unload oxygen more easily to the tissues8.  Other adaptations include 
increased capillary density and blood volume and decreased blood pressure and total 
peripheral resistance which contribute to reduced blood flow demand of the heart8.  
Therefore, during exercise a more trained individual has less strain on the heart.   
 In the peripheral vasculature functional and structural changes also occur with 
exercise training.  Repetitive skeletal muscle contraction on the arterial walls during exercise 
causes an induced shear stress81,82.  The response to the intermittent shear stress from several 
bouts of exercise leads to the release of NO from the endothelium therefore dilating the 
vessel.  The NO machinery may lead to vascular remodeling in order to cope with the shear 
stress imposed during exercise81.  As previously discussed, flow-mediated dilation (conduit 
vessel assessment) and pulse wave analysis (resistance vessel assessment) are barometers of 
vascular health.  Although literature conflicts, the general consensus is that FMD and PWV 
measures improve in response to exercise training83,84.  In a recent meta-analysis, FMD was 
found to improve with exercise training, regardless of exercise modality85,86.  The magnitude 
of change did appear to be related to the exercise intensity and duration.  Tanaka et al. (1998) 
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found pulse wave velocity to be 30% lower in aerobically trained women compared to 
sedentary women87.  Resistance vessel adaptation may be due to neuro-humoral mechanisms 
improving vasomotor function82.  
2.5 Clinical Relevance of Autonomic and Vascular Function 
 The structural components of the autonomic nervous and cardiovascular system and 
their mechanisms of control are altered by several controllable (exercise, diet, smoking) and 
uncontrollable (age, gender, race, family history) factors.  Both controllable and 
uncontrollable factors have an important role in the development of cardiovascular diseases.  
Age, gender and race predispose an individual to autonomic imbalance and vascular 
dysfunction associated with cardiovascular disease, which may be accelerated by controllable 
factors.  In this section, I will discuss predisposed factors (aging, gender and race) that affect 
autonomic and vascular function, and examine the impact of cardiovascular disease on 
autonomic and vascular properties.   
 2.5.1 Impact of Age and Gender 
 Aging is associated with a decline in cardiovascular adaptations, neural control and 
aerobic capacity, which accelerates with advancing age8,88.  Deteriorations in both the 
cardiovascular and nervous system with aging contributes to endothelial dysfunction, arterial 
stiffness, and increased sympathetic activity8.  All of these factors are apparent during 
exercise where blood flow is not as tightly regulated and maximal heart rate and cardiac 
output are reduced.   
 Structural and functional changes occur in the heart and blood vessels during the 
aging process leading to “stiffer” vasculature.  As previously discussed, surrounding the 
tunica media is an extracellular matric composed of collagen, elastin and a sheath of 
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microfibrils to maintain the vessel’s integrity.  During aging, microfibrils disappear causing 
the vessel to slowly lose elasticity and impede the control of blood flow89.  The smooth 
muscle of the tunica media can also alter vascular stiffness by displacing force on the vessel 
walls.  Carroll et al. (1991) infused nitroprusside, a vasodilator, in patients with dilated 
cardiomyopathy across young, middle and older aged groups90.  The oldest group had the 
greatest reduction in aortic stiffness, suggesting augmented smooth muscle tone contributes 
to increased stiffening with age.  Due to these structural changes, PWV is greater91 and FMD 
is lower92 in older individuals.  Age-related changes in PWV and FMD suggest arterial 
thickening and stiffness and endothelial dysfunction are due to the increased presence of 
atherosclerosis, which leads to the development of cardiovascular diseases93. 
 The loss of baroreflex sensitivity may be in part due to vascular stiffening in the 
regions where baroreceptors are found.  With aging, there is less stretch in the arterial wall 
and therefore a reduced ability of baroreceptors to transmit signals94.  Older individuals also 
appear to have diminished response to "-adrenergic receptors and elevated plasma levels of 
norepinephrine95.  The excess plasma norepinephrine often, called ‘spillover’ in the elderly, 
is believed to be due to an increase in sympathetic discharge and reduced uptake at nerve 
junctions.  The prolonged exposure to norepinephrine spillover seen with aging desensitizes 
"-adrenergic receptors causing smooth muscle to remain vasoconstricted19. 
 Heart rate modulation reflects the aging process through a decreased maximal heart 
rate and variability.  Increased sympathetic activity is associated with aging and can be 
detected as a decreased HRV96-98.  Interestingly, the effect of aging on HRV is not linear 
throughout the entire life span.  Through childhood, HRV steadily increases up to 10 years 
old99, after which, it linearly increases until 60 years old followed by a decline in later 
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decades.  Developmental changes in the cardiovascular system account for a younger 
individuals heart to respond differently than an adult heart100.  Older age is associated with 
decreased HF and increased LF/HF, suggesting that the sympathovagal balance progressively 
increases and parasympathetic tone decreases with age11.  
 Generally females have been found to have significantly lower HRV parameters than 
men suggesting an enhanced parasympathetic tone97,101,102.  In addition, during periods of 
cardiac stress, women have been found to have greater indices of vagal activity compared 
with men103.  The mechanisms responsible for the observed gender differences have not been 
completely elucidated; however, some researchers have suggested that female hormones are 
involved.  Estrogen, for example, has been found to alter calcium and potassium flux in 
cardiomyocytes, which would affect catecholamine uptake and change ANS function104.  
Women also have a lower cardiovascular risk compared to men, suggesting that the lower 
HRV found in women may provide cardio-protection against arrhythmia and atherosclerosis 
development105.  Gender influences seem to disappear between 40-60 years old101,105 and 
may be associated with menopause or a general decline in parasympathetic activity. 
 2.5.2 Impact of Race 
 In a recent publication in the New England Journal of Medicine, researchers found 
African-Americans had much higher incidences of heart failure that develops at a younger 
age compared to other races106.  The incidence of CVD affects African-Americans (AA) 
disproportionally, believed to be largely attributable to the higher prevalence of CVD risk 
factors.  African-Americans have the higher rates of obesity107, hypertension108 and a higher 
prevalence of type-2-diabetes than Caucasian counterparts109.  In addition, AA have a 
significantly lower exercise capacity107.  Racial differences in CVD risk factors are complex 
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and multifactorial and may relate to vascular and autonomic tone.  However, the extent of 
racial influence on vascular and autonomic measures is not yet fully understood. 
 Arterial wall function may vary between AA and Caucasians leading to alterations in 
vascular homeostasis.  Lang et al.110 found vasodilation in response to brachial artery 
infusion of isoproterenol (a vasodilator) was significantly attenuated in AA.  Other research 
has also found FMD to be notably blunted in AA111-113, suggesting that the predisposition AA 
have to development of CVD risk factors may begin with endothelial dysfunction.  The loss 
of endothelial nitric-oxide synthase activity and bioavailability of nitric oxide to the smooth 
muscle in the arterial wall may bring about flawed cell signaling and impairing vasodilation; 
in turn, contributing to the pathogenesis of CVD and explain the increased risk in AA.  In 
addition to FMD, pulse wave analysis in AA has suggested they have a higher prevalence of 
arterial stiffness than that of Caucasians at rest114-118.  Reasons for this difference are not 
clear, but may relate to racial differences in vessel-wall structure117.  AA may have a smooth 
muscle phenotype and activity that affects the proportion of collagen, thereby influencing 
vascular stiffness49. 
 Interestingly, few studies have linked conduit (FMD) and resistance (PWV) vessel 
function with autonomic (HRV) function, especially in relation to race.  Reduced arterial 
stiffness (PWV) has been correlated with parasympathetic activity119,120 in healthy, 
Caucasian individuals and sympathetic activity121 in healthy, Asian individuals, suggesting 
race may influence autonomic activity. Pinter et al.122 found FMD positively correlated with 
parasympathetic HRV parameters, suggesting endothelial NO may mediate both functions.  
The autonomic nervous system and endothelial factors work together to maintain vascular 
tone, and NO may augment vagal tone in healthy individuals123.  However, this study was 
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limited to a younger, male sample with no race differences reported. Presently, research 
investigating the effects of race on FMD, PWV and HRV function, and the relationship of 
these variables to each other, is limited.  
 African-Americans show signs of premature deterioration of the autonomic nervous 
system.  Table 2.2 presents studies that have examined racial differences in HRV 
measurements, many of which are conflicting.  Initially, Liao and colleagues (1995) found 
AA to have lower LF (sympathetic activity) and greater HF (parasympathetic activity) in the 
ARIC (Atherosclerosis Risk in Communities) longitudinal study conducted in 27% AA 
adults12.  On the other hand, Zion et al. (2003) and Faulkner et al. (2003) reported lower HF 
(parasympathetic modulation) in AA adolescents and young adults124,125.  Choi et al. (2006) 
has also demonstrated that AA subjects had lower HRV (decreased HF) than their Caucasian 
aged-matched counterparts11.  In particular, this study showed younger AA subjects to have 
HRV indices that were comparable to older Caucasian participants.  This is interesting 
because it suggests that young AA may show the beginnings of vascular and autonomic 
dysfunction, again, predisposing them to CVD risk factors earlier in life.  Autonomic 
dysfunction may be even more hindering during exercise, where switching from 
parasympathetic to sympathetic activity is blunted.  Inability of the heart to meet oxygen 
demands by increasing rate may make exercise feel more difficult and reduce aerobic 
capacity.  From these studies it remains unclear what effect, if any, race has on autonomic 
balance during exercise.  Further research is necessary at rest and during exercise to further 
determine why racial disparities exist in the prevalence of diseases such as hypertension and 





Table 2.2. Studies examining the impact of race on HRV parameters. 
Study Population n (%AA) Age (yr) Spectral Analysis Comments 
Liao et al.  
1995 Atherosclerosis 1984 (27%) 45-64 
!HF, LF/HF  
"LF 
AA had higher HRV than 
CA; Supine, 2-min data  
Urbina et al. 
1998 
Healthy 
adolescents 39 (50%) 13-17 " LF/HF 
AA had higher HRV than 
CA; Supine Holter 
monitoring  
Guzzetti et al. 
2000 Hypertension 52 (50%) 
45±2 (AA) 
46±2 (CA) "LF, LF/HF  
AA had higher HRV than 
CA; 24hr Holter monitoring 
Faulkner et al. 
2003 
Healthy 
adolescents 75 (19%) 15±1.6 "HF, LF 
AA had lower HRV than 
CA; 24hr Holter monitoring 
Zion et al.  





AA had lower HRV than 
NA; Seated, 5-min data 
Gutin et al. 
2005 
Healthy 
adolescents 304 (52%) 14-18 
!RMSSD 
"LF/HF 
AA had higher HRV than 
CA; Supine, 1-min data 
Lampert et al. 
2005 Healthy adults 256 (19%) 
45±3 (AA) 
50±1 (CA) "SDNN, LF, HF 
AA had lower HRV than 
CA; 24hr Holter monitoring 
Wang et al. 
2005 
Healthy 
adolescents 166 (61%) 16±2 
!RMSSD, HF 
"LF/HF 
AA had higher HRV than 
CA; Supine, 4-min data 
Choi et al.  





AA had lower HRV than 
older CA; Seated, 3-min data 
Sloan et al. 
2008 Healthy adults 757 (56%) 40±3.7 "LF, LF/HF 
AA had lower HRV than 
CA; Seated, 5-min data 
Li et al.  
2009 Healthy adults 399 (53%) 15-31 
!RMSSD, HF 
 
AA had higher HRV than 
CA; Supine, 30-second data 
Fuller-Rowell 
et al. 2013 Healthy adults 1037 (20%) 
50.9±10.6 (AA) 
54.5±11.6 (CA) -- 
No race difference in 
RMSSD; Seated, 5-min data 
AA= African American; CA= Caucasian; NA= Non-African American; HRV= Heart rate variability. Spectral 
analysis described in relation to AA study groups. 
 
 2.5.3 Impact of Cardiovascular Diseases 
 The Bogalusa Heart Study is one of the largest longitudinal studies in the United 
States that investigates the development of CVD among a population with a significant 
proportion of AA.  The Bogalusa Heart Study has shown the pathological evidence of 
atherosclerosis begins in early childhood and is predictive of adulthood risk for CVD126.  AA 
have demonstrated greater atherosclerotic lesions than Caucasian counter parts across several 
age groups, suggesting AA begin the early stages of atherosclerosis earlier in life127. 
 Decreased FMD and increased PWV are observed with the progression of 
cardiovascular disease.  The vascular endothelium is functionally involved in regulating 
vascular tone, thrombosis and platelet adhesion.  The development of atherosclerosis 
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interferes with these functions as well as the NO) that causes vasodilation128.  Endothelial 
dysfunction is believed to be one of the earliest stages of atherosclerosis, measured by FMD, 
and precedes hypercholesterolemia, hypertension, diabetes mellitus and obesity67,92.  The loss 
of endothelial cell integrity reduces NO bioavailability, which contributes to arterial stiffness, 
measured by PWV. 
 Hijmering et al. (2002) demonstrated that sympathetic stimulation significantly 
impairs FMD response in healthy individuals129.  In addition, Tsuji et al. (1996) demonstrated 
in apparently healthy individuals a reduced HRV (high sympathetic activity) was associated 
with greater risk for cardiac events, suggesting autonomic and endothelial (dys)function work 
concomitantly130.  A study by Huikrui and colleagues (1995) examined long-term HRV in 
coronary artery disease patients.  SDNN independently predicted the progression of coronary 
artery disease131. Kleiger et al. (1987), observed patients recovering from myocardial 
infarctions and found those with the lowest HRV (lowest SDNN) had the greatest risk of a 
sudden death32.  These studies point to the involvement of autonomic regulation in disease 
suggesting sympathetic tone directly impacts the vascular endothelium at rest.  The 
mechanism of autonomic dysfunction may be related to an increase in arterial stiffness and 
altered endothelial properties. 
2.6 Conclusion and Future Directions 
 In summary of this review, the heart and vast network of blood vessels share the 
common purpose to circulate blood to the necessary tissue in order to maintain homeostasis.  
The components of the cardiovascular system are subject to autonomic neural control, both 
of which are challenged under various physiological conditions including physical activity.  
Assessing the neural and vascular function requires a number of tools in order to fully 
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understand the relationships between structural and functional responses at rest and during 
exercise. 
 A large number of experimental and clinical studies involve the measurement of 
HRV, FMD and PWV, and have widespread acceptance as non-invasive tools for identifying 
potential abnormalities in cardiac autonomic function.  Though standard methodologies have 
been established31,42, there is substantial inter-individual variation including age, gender and 
race that should be controlled for.  Future research will utilize non-invasive assessments to 
examine differences in apparently healthy adults and association between autonomic and 
cardiovascular function.  The combination of PWV, FMD and HRV in assessments of 
cardiovascular disease and autonomic imbalance may increase overall predictive accuracy of 
these tools and provide a more holistic approach to the condition of cardiovascular health. 
 Determinants of HRV, FMD and PWV include age, gender and race.  AA are at 
greater risk for developing CVD and CVD risk factors suggesting structural and functional 
changes may be occurring in the vasculature as well as autonomic imbalance at younger age 
compared to Caucasian counterparts.  The importance of the autonomic system on the 
cardiovascular system is often overlooked in research despite autonomic modulation of the 
cardiovascular system being associated with adverse prognosis.  The measurement of HRV is 
noninvasive and inexpensive, so it is important to relate HRV to the physiological 
counterparts to understand how changes in HRV parameters may be associated with CVD 
development.  Presently, research on the relationship of HRV and race has yielded 
inconsistent results.  In addition, few studies have examined the link between of neural and 
cardiovascular control in relationship to race.  However, research has highlighted that AA are 
at greater risk for CVD.  Future research on AA is important to identify mechanisms behind 
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the development of CVD and how exercise mediates changes in autonomic function.  
Exercise training in AA can lead to significant gains in fitness, improved vascular function 
and autonomic balance, thus having the potential to delay onset of CVD, and major CVD 
related risk factors.  Further research is necessary to identify an exercise intervention 
(program length, duration, intensity, mode) that optimizes HRV improvements.  The use of 
FMD, PWV and HRV in future research including exercise interventions may allow for 
better risk stratification in healthy and clinical populations and provide valuable non-invasive 
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CHAPTER 3. THE EFFECTS OF EXERCISE TRAINING ON BRACHIAL ARTERY 
FLOW-MEDIATED DILATION: A META-ANALAYSIS 
 
3.1 Introduction 
 In the last decade, brachial artery flow mediated dilation (BAFMD) utilized to assess 
endothelium-dependent vasodilatory function has become a popular barometer of vascular 
health, highly dependent on intact nitric oxide (NO)-machinery1,2.  Cardiovascular (CV) risk 
and future CV events in both asymptomatic3,4"and diseased populations5-7 have been 
associated with the BAFMD assessment.  Endothelial dysfunction is considered an important 
early event in the development of atherosclerosis, preceding gross morphological signs and 
clinical symptoms of the inflammatory process and future CV disease8. 
  Growing evidence suggests exercise training (ET) improves vascular structure, NO 
bioavailability and reduces CV disease risk factors9, therefore making BAFMD assessment a 
common outcome measure to determine the efficacy of physical activity and ET10.  
Resistance and aerobic ET have demonstrated improved BAFMD in short and long term ET 
programs11,12.  The mechanical effects of muscular contractions during ET contribute to an 
acute oscillatory shear stress thought to serve as major stimulus for adaptations and release of 
NO, particularly in ‘flow-sensitive’ arteries13.  
  To date, few statistical reviews have examined the effects of ET on BAFMD1,14-16.  
These reviews were limited by a small special population including type 2 diabetics14 or 
children16 and lacked comprehension of potential inclusive studies and moderating factors 
(modality, length of program, exercise volume, fitness status) of ET15.  Thus, this systematic 
review will explore the effect of ET on BAFMD and potential ET and participant 




 3.2.1 Search Strategy and Selection Criteria 
 In a systematic search of Pubmed (from 1999 to 2013), 913 citations were obtained 
using the search terms “brachial artery flow-mediated dilation”, “vasodilation” or 
“endothelial function” or “vascular reactivity” and “exercise” or “training”.  Due to 
technological advances and standardization of methods, articles prior to 1999 were excluded.  
In addition, reference lists of original and review articles were analyzed manually for full-
text retrieval.  The search of studies was not restricted by language, age or publication status.   
After an initial screening of articles based on title and abstract, potentially relevant studies 
investigating BAFMD and ET were assessed for inclusion and quality in the current meta-
analysis (Figure 3.1).  This review is in accordance with PRISMA statement guidelines17. 
 
Figure 3.1. Study search and selection process.  FMD flow-mediated dilation. 
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Original studies were included if they met the following criteria: 1) the use of human 
subjects; 2) duration of ET intervention was (1 week; 3) vascular function was evaluated by 
BAFMD with forearm occlusion; 4) data concerning pre- and post- ET intervention BAFMD 
[mean and standard deviations (SDs)] were reported.  Studies involving manipulation (i.e. 
blood flow restriction, functional electrical stimulation, etc.), detraining or ET with 
additional interventions such as diet or pharmacological agents were excluded.     
 3.2.2 Quality Assessment and Data Extraction  
 Two reviewers (K.A. and A.S.) independently selected studies, extracted data and 
assessed the publications according to inclusion criteria.  Discrepancies in 
inclusion/exclusion were resolved by a third party reviewer (N.J.).  Reviewers judged the 
quality of studies by the Jadad et al. (1996)18 3-item scoring instrument, which evaluates the 
study quality in terms of randomization quality, blinding, and reporting of 
withdrawals/dropouts.  Studies scoring a 0 represented the lowest level of quality, with a 
possible score between 0 and 5.  However, since the criterion item regarding blinding 
requirements was not applicable to ET interventions, the scoring was modified to assess the 
blinding of the outcome assessment (BAFMD); therefore, the highest possible Jadad score 
was 4. 
 The primary outcome of the present study was to investigate how ET impacts 
BAFMD.  For each study, participant characteristics [age, sex, number of participants]; 
health status of participants [healthy, CV disease, metabolic diseases, hypertension, obesity, 
other]; ET characteristics [length of ET, duration of ET bout, frequency of sessions, ET 
intensity, pre- and post- fitness level]; BAFMD characteristics [baseline and peak artery 
diameter, absolute change of FMD, FMD mean and standard deviation (SD)]; and 
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methodological considerations [probe strength, cuff placement] were retrieved.  ET intensity 
(1=very light-light, 2=moderate, 3=hard-near maximal), duration (<150min/week, 
(150min/week) and baseline fitness level (percentile category) were rated according to 
ACSM’s Guidelines for Exercise Testing and Prescription19.  When necessary, corresponding 
authors were contacted for unpublished data that was not reported or displayed numerically 
in the content of the paper. 
 3.2.3 Statistical Analysis 
 Statistical analysis was performed using SPSS 20.0.0 statistical software for Mac OS 
X (SPSS Inc., Chicago, IL).  Descriptive data are reported as mean ± standard deviation 
(SD).  BAFMD is determined as the percent change in brachial artery diameter after a 5-
minute period of forearm occlusion, and is displayed as absolute (mm) and relative (%) 
change.  To facilitate comparison of results across studies, treatment and control effect sizes 
were calculated by the differences in the means pre- and post-intervention divided by the pre-
intervention standard deviation20.  Each mean effect size (ES) was calculated as a weight 
mean difference with 95% confidence intervals20.  Data were screened for normality using 
skewness, kurtosis and normal quantile plots.  Publication bias was examined by funnel plot 
asymmetry as well as two formal tests: Egger’s weighted regression test21 and Begg and 
Mazumdar’s rank correlation test22.  In the case of publication bias, the number of 
unpublished trials containing ES of zero is defined as [K(dk-dc)]/dc, where K=number of 
obtained studies, dk=mean ES of obtained studies, and dc=trivial ES to which the obtained ES 
would be reduced20.   
 Differences in effect of ET on BAFMD were assessed in the following subgroups: 
age of participants at baseline ()30 versus 31-59 versus (60 years), disease status (diseased 
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versus asymptomatic), fitness change, training type (aerobic versus resistance ET versus 
combined aerobic and resistance ET versus control), duration of ET program ((12 weeks 
versus <12weeks), and ET intensity (very light-light, moderate, high-near maximal), volume 
(<150min/wk versus (150min/wk), trial quality ()2 versus >2).  Age and duration of training 
subgroups were determined in order to equally distribute ES.  Correlation between fitness 
and BAFMD ES was evaluated using the Spearman-rank correlation analysis.  To counteract 
multiple comparisons on the same data set, a Bonferroni correction was utilized to determine 
the critical P-value for each comparison. "
3.3 Results 
 3.3.1 Literature Search and Publication Bias 
 A total of 191 related studies were identified from 1999 to 2013 for eligibility 
screening into the present study (Figure 3.1).  Of these, 120 studies were excluded because 
they were acute ET (n=65) or detraining (n=5) regimens, a manipulation or therapy was 
applied (i.e. functional electrical stimulation) (n=14), ET plus additional interventions were 
applied (n=3), and flow mediated dilatation was not performed with forearm occlusion 
imaging the brachial artery (n=13), or BAFMD data was not available after author contact 
(n=16).  Finally, of the 66 studies included in the final analysis, the sample size ranged 
between 7 and 146 participants with a total of 1865 ET intervention and 635 control subjects 
(Table 3.1).  The mean and modal quality of studies (Jadad score) were 2 and 1 (range, 1-4), 
respectively. 
 Asymmetry of funnel plots suggests a potential publication bias.  To confirm, the 
intercept of the regression relation effect between standard normal deviate and the inverse 
standard error was significantly different from zero (intercept=0.22, P<0.001), and the 
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Kendall-tau correlation coefficient between the ES and its variance was also significant 
(r=0.60, P<0.001).  The wide spread of sample size among the present studies and absence of  
‘negative’ studies potentially contributed to the bias.  It is estimated that the number of 
unpublished studies needed to bring the mean effect to a non-significant level is 411 
studies20. 
 3.3.2 Study Characteristics 
 The main demographic characteristics of the studies are described in Table 3.1.  The 
mean age was 47±19 (range, 9-81) years and percentage of men was 50%.  Seven of the 
studies included children ranging from 8-14 (median, 11)23-29.  The populations of the studies 
primarily included CV-related diseases (n=19), asymptomatic/healthy subjects (n=18), 
metabolic related diseases (n=10), hypertension (n=10), overweight and obesity (n=7) and 
thyroid related issues (n=2).   
Prior to ET intervention, the mean baseline artery diameter and BAFMD were 
3.92±0.50mm (range, 2.61-5.33mm) and 5.5±2.4% (range, 0.9-13.6%), respectively.  Post-
ET intervention groups mean BAFMD improved to 8.1±3.9% (P<0.0001) while there was no 
change in control group (5.4±1.9%, P=0.72).  The absolute change of BAFMD in trained 
groups (n=22) was significant from pre- to post-intervention (0.26±0.11 to 0.31±0.13mm, 
P=0.01), and the control group (n=11) absolute change in diameter decreased (0.24±0.07 to 
0.22±0.07mm, P=0.23).  However, baseline artery diameter remained the same post-
intervention in exercise training (3.92±0.50mm) and control groups (4.04±0.56mm).  The 
mean ET intervention lasted 12±8 (range, 1-52) weeks (Table 3.1).  ET modalities included 
aerobic (n=58), resistance (n=17), combined aerobic and resistance ET (n=13), and control 
(n=39) groups. Regardless of ET modality, the average ET intervention consisted of a mean 
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3.5±1.5 (median, 3) sessions per week (n=87) and 46.9±13.8 (median, 45) minutes per 
session (n=76).  The median intensity was moderate (n=84) and mean ET volume was 
167±93 (median, 159) minutes per week.  
 3.3.3 Effect of ET on BAFMD 
 One hundred twenty-three mean, weighted ES were derived from 66 studies.  
Overall, ET induced a significant increase of BAFMD (trained ES, 8.38, 95% CI 6.16-10.59, 
P<0.0001).  Eighty of the 88 training ES (91%) were larger than zero.  The control group 
mean ES was -0.61 (95%CI, -2.15-0.94) and suggests control groups on average did not 
change during the interventional period (CI encompasses 0).  No differences were observed 
between training modalities when compared to the control; aerobic ET tended to have the 
greatest ES (9.30; 95%CI, 6.29-12.31), followed by combined aerobic and resistance ET (ES, 
7.62; 95%CI, 2.32-12.92) and resistance ET (ES, 5.80: 95%CI, 1.29-10.30) (Table 3.2).  Of 
the 66 studies (71 ES) that reported a pre- and post-ET intervention fitness measure, 100% 
showed an improvement in fitness (i.e. VO2peak, one-repetition maximum, maximal voluntary 
contraction).  The mean percent change in fitness was 16±12% (median, 12%).  A modest 










Table 3.1. Participant and exercise intervention characteristics of studies included in the meta-analysis. 
Study Characteristics 
 
Exercise Intervention Characteristics 
















Clarkson et al.  J Am Coll Cardiol Healthy Adults 20±0 100 25/0  10 RA 7 -- -- 
Maiorana et al.  J Am Coll Cardiol T2DM 52±2 88 16/0  8 RA 3 60 3 
Gokce et al.  Am J Cardiol CAD 59±10 78 40/18  10 A 3 30-40 -- 
Allen et al.  Med Sci Sport Exer Healthy Adults 26±6 100 14/14  4 R 5 20 2 
Kobayashi et al.  Circ J CHF 55±2 71 14/14  12 A 2-3 30 2 
Walsh et al.  Eur Heart J HC 55±2 73 11/11  8 RA 3 45-60 3 
Walsh et al.  J Appl Physiol CAD 52±2 100 10/0  8 RA 3 45-60 3 
Guazzi et al.  J Appl Physiol CHF 52±5 100 16/0  8 A 4 40 3 
Kelly et al.   J Pediatr Overweight Children 11±4 45 10/10  8 A 4 50 3 
Vona et al.  Am Heart J AMI 56±6 77 28/24  12 A 3 60 2 
Watts et al.  J Am Coll Cardiol Obese children 14±2 65 23/0  8 RA 3 60 3 
Watts et al.  J Pediatr Obese children 9±2 43 14/14  8 A 3 60 2 
Belardinelli et 
al.  
Int J Cardiol HTN 56±15 100 30/0  8 A 3 70 2 
Moriguchi et al.  Hypertens Res HTN 43±10 72 25/0  12 A 2 60 2 
Rakobowchuk 
et al.  
J Appl Physiol Healthy adults 23±4 100 28/0  12 R 5 60 3 
McGowan et al.  Eur J Appl Physiol HTN 66±6 78 9/9  8 R 3 -- 1 
Miche et al.  Clin Res Cardiol T2DM/CHF 67±6 86 20/22  4 RA 3 -- 2 
Olson et al.  Med Sci Sport Exer Overweight adults 38±1 0 15/15  52 R 2 -- -- 
Casey et al.  Exp Biol Med Healthy adults 21±1 45 24/18  12 R 3 35 3 
Casey et al.  Eur J Appl Physiol Healthy adults 59±5 0 23/0  18 R,A 2 35,35-40 2,3 
McGowan et al.  Clin Sci Healthy adults 28±14 78 9/9  8 R 3 -- 1 





Table 3.1 continued. Participant and exercise intervention characteristics of studies included in the meta-analysis. 
Study Characteristics  Exercise Intervention Characteristics 
















Westhoff et al.  Kidney Blood Press 
Res 
HTN 68±5 50 25/27  12 A -- -- 3 
Belardinelli et 
al.  
Circ Heart Fail CHF 59±11 84 88/0  8 A 3 60,31 3 
Sixt et al.  Eur J Cardiovasc Prev 
Rehabil 
IGT/CAD 64±6 74 17/23  4 A 6 -- 7 
Tinken et al.  J Physiol Healthy Adults 22±2 100 13/7  8 A 3 30 3 
Westhoff et al.  J Hypertens HTN 53±2 46 12/12  12 A 3 30 2 
Baynard at al.  Eur J Appl Physil MetSyn 52±1 48 21/0  1 A 10 60 2 
Dobrosielski et 
al.  
Med Sci Sport Exerc Older Adults 81±1 100 12/12  4 R 4 20 2 
Munk et al.  Am Heart J PCI 57±14 83 20/20  24 A 3 60 3 
Murphy et al.  Int J Pediatr Obes Overweight Children 10±2  23/12  12 A 5 30 -- 
Tjonna et al.  Clin Sci Overweight Children 14±0  20/22  12 A 2 40 3 
Vona et al.  Circulation AMI 56±6 65 159/50  4 A,R, 
RA 
4 60 2 
Wray et al.  Clin Sci HTN 71±2 100 6/0  6 A 3 60 3 
Xiang et al.  Eur J Endocrinol sHT 53±8 0 53/0  24 A 4-6 40-45 2 
Allen et al.  Free Radic Biol Med PAD 68±10 55 33/0  12 A 3 30-40 3 
Credeur et al.  Med Sci Sport Exerc Healthy adults 22±1 42 12/0  4 R 3 20 2 
Desch et al.  Diabetes Obes Metab CAD 62±6 73 14/12  24 A 7 30 2 
Okada et al.  J Atheroscler Thromb T2DM 62±9 55 21/17  12 RA 3-5 40 -- 
Tinken et al.  Hypertension Healthy adults 22±2 100 11/0  8 R 3 60 2 
Van 
Craenenbroeck 
et al.  
Basic Res Cardiol CHF 61±2 79 21/17  24 RA 3 60 3 
Anagnostakou 
et al.  




Table 3.1 continued. Participant and exercise intervention characteristics of studies included in the meta-analysis. 
Study Characteristics 
 
Exercise Intervention Characteristics 
















Hermann et al.  Am J Transplant HTx 53±11 81 14/13  8 A 3 60 3 
Kwon et al.  Diabetes Metab J T2DM 56±9 0 25/15  12 A,R 5 60 2,1 
Molmen-
Hansen et al.  
Eur J Prev Cardiol HTN 52±8 56 48/25  12 A 3 38,47 3,2 
Okamoto et al.  Eur J Appl Physiol Healthy adults 19±1 77 13/0  10 R 2 -- 2 
Pierce et al.  Clin Sci Healthy adults 63±1 42 26/10  8 A 6-7 45 2 
Reameriz-Velez 
et al.  
J Obstet Gynaecol Res Pregnant adults 20±2 0 24/26  16 A 3 60 1 
Seeger et al.  Diabetes Obes Metab T1DM 11±2  7/0  18 A 2 40-60 -- 
Akazawa et al.  Nutr Res Healthy adults 59±5 0 11/10  8 A 3 40-60 2 
Barone Gibbs et 
al.  
Atherosclerosis T2DM 58±5 62 49/63  26 RA 3 45 3 
Billinger et al.  JNPT Stroke 61±5 67 9/0  8 A 3 30-40 3 
Cornelissen et 
al.  
Eur J Prev Cardiol CAD 62±1 84 146/0  12 A 3 90 3 
Credeur et al.  Atherosclerosis CHF 62±8 40 10/10  4 R 3 20 2 
da Silva et al.  Diabetes Res Clin Pr MetSyn/ T2DM 58±6 35 20/11  6 A 4 50 1,3 
Hopkins et al.  Eur J Prev Cardiol Twin children 14±1 33 24/0  8 A 3 45 3 
Hunt et al.  J Appl Physiol Healthy adults 26±4 100 9/0  4 R 3 -- 1 
Naulnim et al.  Am J Cardiol HTN 60±2    12 A 4 40-50 2 
Rakobowchuk 
et al.  
Exp Physiol Healthy adults 24±3 35 20/0  6 A 3 40 2,3 
Swift et al.  Br J Sports Med Obese adults 57±6 0 132/23  24 A 3-4 -- 1 
Xiang et al.  Exp Clin Endocrinol 
Diabetes 
HT 45±9 0 86/0  24 A 4 40-45 2 
Beck et al.  Exp Biol Med Prehypertension 21±3 70 28/15  8 A,R 3 60 3 





Table 3.1 continued. Participant and exercise intervention characteristics of studies included in the meta-analysis. 
 
Study Characteristics   Exercise Intervention Characteristics 
















Kitzman et al.  J Am Coll Cardiol HF 70±7  24/29  16 A 3 60 3 
Mitranun et al.  Scand J Med Sci 
Sports 
T2DM 61±3 35 14/29  12 A 3 40 3 
Spence et al.  J Physiol Healthy adults 27±5 100 23/0  24 A,R 3 60 -- 
T2DM type 2 diabetes mellitus; T1DM type 1 diabetes mellitus; MetSyn metabolic syndrome; IGT impaired glucose tolerance; CAD coronary artery disease; HF 
heart failure; CHF chronic heart failure; HC hypercholesterolemia; HTx heart transplant; AMI acute myocardial infarction; PCI percutaneous coronary intervention; 
HTN hypertension; sHT subclinical hyperthyroidism; HT Hashimoto's thyroiditis; I intervention; C control; A aerobic; R resistance; RA combined aerobic and 




 3.3.4 Subgroup and Advanced Analyses 
 Results of subgroup analyses from BAFMD are summarized in Table 3.2.  
Overlapping confidence intervals of each with-in comparison suggested no difference in age 
(!30 versus 31-59 versus "60 years, P=0.11), baseline fitness level (<50th percentile or "50th 
percentile, P=0.65) and baseline artery diameter (<4.00mm or "4.00mm, P=0.31). Compared 
to asymptomatic subjects, diseased patients had a significantly higher BAFMD ET effect 
(asymptomatic, 3.18, 95%CI, 1.90-4.46 versus diseased, 10.44, 95%CI, 7.53-13.34; 
P=0.0007).  When examining disease categories, CV disease (n=25, 14.11, 95%CI, 7.63-
20.59), overweight/obesity (n=9, 9.93, 95%CI, 7.49-12.36) and hypertension (n=13, 7.61, 
95%CI, 3.82-11.41) groups had significantly greater BAFMD ES than the 
asymptomatic/healthy category (n=24, 3.45, 95%CI, 1.28-4.73) (P=0.001).  Subjects with a 
baseline BAFMD <5% appeared to have a larger ES than those with a baseline BAFMD "5% 
(<5%, 8.23, 95%CI, 5.28-11.17 versus <5%, 3.94, 95%CI, 1.82-6.06; P=0.01).  
Methodologically, studies with higher trial quality (>2) (P=0.003) showed statistically 
significant treatment effect, while studies conducted after 2006 (ES, 8.30; 95%CI, 5.76-
10.96) tended to have a smaller effect than studies conducted prior to 2006 (ES, 8.70; 
95%CI, 8.14-9.26) (P=0.06). 
 ET intervention groups had a significantly greater BAFMD ES than the control 
groups in regards to modality, length of ET as well as intensity and ET volume subgroups 
(all, P<0.0001; Table 3.2).  Within subgroups, very light-light ET intensity was not different 
than the control group, but ET at a vigorous to near maximal ET intensity did result in a 
significant improvement in BAFMD (control, -0.42; 95%CI, -2.06-1.21 versus very light-
light, 3.63; 95%CI, -0.57-7.83 versus vigorous-near maximal, 9.29; 95%CI, 5.09-13.47). 
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Furthermore, study groups with an ET duration was !150min/wk had a significant 
improvement in BAFMD compared to those with <150min/wk (control, -0.30; 95%CI, -1.99-
1.39 versus <150min/wk, 4.79; 95%CI 3.08-6.51 versus !150min/wk, 11.33; 95%CI, 7.5-
15.51; Figure 3.2). 
3.4 Discussion 
 The meta-analyses demonstrated that ET interventions contribute to a significant 
increase in BAFMD regardless of ET modality, length of ET, intensity or volume of ET, 
supporting evidence that ET enhances endothelial function13.  In addition, BAFMD was 
associated independently with both ET intensity and duration in a dose-response fashion.   
  Age did not serve as moderator to the changes in BAFMD with ET, 
suggesting that the vasculature remains modifiable throughout the life-span.  The older age 
groups (>31years) tended to have greater BAFMD improvement; suggesting ET can prevent 
age-related loss in endothelial function.  However, since age tended to be a potential 
moderator (P=0.11), it is possible that age specific responses to ET may be masked due to the 
combining of sexes.  Previous research suggests sedentary, middle-aged and older men can 
prevent age-associated loss in endothelial function with regular aerobic ET30 while healthy 
postmenopausal women have no improvements in BAFMD with endurance ET31.  Disease 
status was found to impact the ES of BAFMD with ET, in particular CV diseases, 
overweight/obesity and hypertension, likely due to their higher propensity for vascular 






Table 3.2. Subgroup analyses of potential moderating factors. 
Factor N Effect 95% CI L-Statistic P-value 
Age    4.42 0.11 
   !30 years 28 4.63 (2.91, 6.35)   
   31-59 years 38 10.68 (7.11, 14.24)   
   "60 years 22 9.17 (2.84, 15.49)   
Disease Status    11.29 0.0007 
  Asymptomatic/Healthy 25 3.18 (1.90, 4.46)   
  Diseased 63 10.44 (7.53, 13.34)   
Baseline Level of Fitness    0.21 0.65 
  <50th percentile 52 4.19 (3.31, 7.63)   
  "50th percentile 6 8.63 (-2.09, 19.35)   
Baseline FMD    6.26 0.01 
  <5% 54 8.23 (5.28, 11.17)   
  "5% 69 3.94 (1.82, 6.06)   
Baseline Artery Diameter    1.02 0.31 
  <4.00mm 52 4.80 (2.69, 6.92)   
  "4.00mm 50 7.26 (3.84, 10.67)   
Trial Quality    9.11 0.003 
  !2 63 6.54 (4.11, 8.95)   
  >2 25 13.01 (8.59, 17.42)   
Year of Publication     3.63 0.06 
  <2006 16 8.70 (8.14, 9.26)   
  "2006 72 8.30 (5.76 10.96)   
Type of Exercise    39.34 0.0001 
  Control 35 -0.61 (-2.11, 1.00)   
  Aerobic 58 9.31 (6.08, 12.31)   
  Resistance 17 5.80 (1.29, 10.30)   
  Aerobic and resistance 13 7.62 (2.33, 12.92)   
Length of Training    37.77 0.0001 
  Control 35 -0.61 (-2.11, 1.00)   
  <12weeks 43 8.09 (5.06, 11.13)   
  "12weeks 45 8.65 (5.23, 12.06)   
Intensity    36.42 0.0001 
  Control 32 -0.42 (-2.06, 1.21)   
  Very light-light 9 3.63 (-0.57, 7.83)   
  Moderate 38 8.96 (5.39, 12.53)   
  Vigorous-near maximal 34 9.29 (5.09, 13.47)   
Volume    33.22 0.0001 
  Control 31 -0.30 (-1.99, 1.39)   
   <150min/wk 48 4.80 (3.08, 6.51)   





Figure 3.2. Exercise intensity and volume weighted effect sizes displayed as mean and 95% 
confidence interval.  a) Significantly different from control (P<0.05).  b) Exercise intensity 
very light-light significantly different from vigorous-near maximal (P<0.01) and volume 
!150min/wk significantly different from <150min/wk (P<0.01). 
 
In clinical studies of diabetes mellitus32,33, obesity12 and hypertension34, patients have shown 
a blunted BAFMD.  In addition, this study found the greater change in fitness the greater ES 
of BAFMD, suggesting modifying fitness is important to vascular health.  Low 
cardiorespiratory fitness is an established risk factor for the cardiovascular and total mortality 
independent of CV risk factors35.  Therefore, as ET interventions are applied to patients with 
CV risk factors it is important to consider ET is important to improving fitness and clinical 
symptoms and slow the progression of atherosclerosis, as measured by BAFMD. 
 Evidence supports a significant effect of ET on BAFMD independent of modality or 
length of ET.  The modality with the greatest BAFMD ES was aerobic ET, suggesting 
regular aerobic exercise may be the most beneficial mode to improve vascular function15.  
There were no differences in the magnitude of ES between studies up to 12 weeks versus 
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studies longer than 12 weeks in length.  The ES of BAFMD on ET is associated with both ET 
intensity and volume suggests a dose-response stimulus.  The association with ET intensity 
may be due to greater shear stimulus triggered by increasing intensity36.  This shear stress has 
been shown to unregulated NO production via NO-synthase and increases the release of 
NO37.  These findings demonstrate high-intensity ET may be beneficial in order to optimally 
improve vascular function38,39.  However, no difference was seen between moderate and 
vigorous ET intensity, suggesting moderate intensity can sufficiently improve BAFMD.  
Despite the popular trend of high intensity interval training, there appears to be no benefit of 
higher, potentially riskier, ET intensity for vascular improvement.  Furthermore, maximal 
effort ET for a sustained period of time has been shown to generate reactive oxygen species, 
which hinders vascular function40,41.  Reduced BAFMD may be the consequence of an 
increase in circulating vasoconstrictor agonists (i.e. ANG-II, vasopression and endothelin) 
42,43!"#$ increased oxidative stress44.  NO is believed to play a significant role in buffering 
against oxygen radicals.  If the oxygen stress is elevated as in high intensity exercise, NO’s 
role may shift from a vasodilator to a radical scavenger. 
 Although we believe this to be the most comprehensive review of evidence 
supporting the impact of ET-based intervention on vascular function, variations in the 
methods of BAFMD assessment and reporting of ET characteristics may lead to detectable 
differences and explain the wide variation in the measurement.  Several studies that met the 
minimum inclusion criteria were of poor methodological quality, and few described the 
process of random assignment and blinding of the outcome assessment (BAFMD).  
Additional factors that may potentially influence BAFMD including menopause, diet and 
smoking could not be examined due to the lack of reporting in the included studies.  Future 
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studies should include age and gender information in their report to further clarify the 
evidence supporting different BAFMD responses to ET.  Interestingly, trials over the last 
decade (published !2006) are typically of lower quality, which is potentially a consequence 
of methodological and physiologic guidelines that have been published and the popularity of 
the measurement8,45.  Few of the included studies were longitudinal; 9 of the 66 studies 
reviewed were longer than 20 weeks.  Further research is necessary to establish optimal ET 
interventions for improvement in vascular health, measured by BAFMD. 
  In conclusion, a meta-analysis of 66 studies found ET interventions contribute to a 
significant increase in BAFMD.  Age did not modify BAFMD, suggesting the vasculature is 
modifiable and age-associated changes in BAFMD can improved with ET.  The ES of 
BAFMD is associated with both ET intensity and duration in a dose-response fashion.  
Larger effects were seen with higher intensity, longer duration exercise.  This meta-analysis 
provides evidence that ET interventions improve BAFMD, supporting its marked benefits in 
the primary and secondary prevention and treatment of a variety of CV and metabolic 
disorders. 
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CHAPTER 4. ACUTE EXERCISE ALTERS HEART RATE VARIABILITY TO AN 
ORAL GLUCOSE TOLERANCE TEST IN OVERWEIGHT MEN: A PILOT STUDY 
 
4.1 Introduction 
 Overweight/obese individuals display impaired glucose metabolism and autonomic 
imbalance, measured by heart rate variability (HRV), which is associated with increased risk 
for cardiovascular morbidity1.  Following glucose ingestion, components of HRV have been 
shown to shift toward greater sympathetic tone in healthy and obese adults2,3.  In obese 
patients the change in autonomic function is attributed to chronic hyperinsulinemia 
desensitizing the sinoatrial node to both sympathetic and parasympathetic activity3.  In 
addition, obesity is characterized by increased adiposity, which has correlated with 
increasing autonomic imbalance4 and cardiovascular disease risk1. 
 Exercise training has been found to reduce resting sympathetic activity5,6, reduce 
body fat5, and improve glycemic control7 in patients with obesity.  Although exercise 
intensity and duration are recognized as factors that affect blood glucose8, few studies have 
examined the impact of acute exercise at different intensities on HRV in response to glucose 
ingestion.  A single bout of aerobic exercise can improve glucose metabolism up to 48-hr 
after exercise, potentially due to increased glucose uptake to support glycogen resynthesis9 or 
from more complete oxidation of intramuscular lipids and lipid species10.  However, studies 
of exercise intensity report conflicting results on the impact of exercise intensity on glucose 
concentrations.  Previous research suggests a single bout of aerobic exercise at a higher 
intensity (as a percentage of maximal cardiorespiratory fitness; VO2max) improves glucose 
levels 24-hr after exercise11,12, while others report low intensity exercise is ideal13.  In 
addition, exercise results in increased plasma catecholamines, a stimulator of glucose 
metabolism and sympathetic activity14.  Lower exercise intensity may reduce HRV in 
!
 79 
response to glucose ingestion due to lower circulating catecholamines or different substrate 
utilization.  These cellular and molecular adaptations occurring in response to acute exercise 
may provide insight to how exercise intensity influences mechanisms of glucose and 
sympathetic regulation. 
 Lower exercise intensity may provide a similar metabolic and cardiovascular 
response after exercise and reduce the subjective discomfort that obese individuals typically 
experience with exercise.  To our knowledge, no studies have compared alterations in HRV 
produced by acute aerobic exercise at a low/moderate intensity compared to high intensity 
exercise.  We hypothesized that a single bout of exercise would increase autonomic response 
to an OGTT and exercise intensity would mediate the response.  The purpose of this study, 
therefore, was 1) to investigate HRV during an oral glucose tolerance test (OGTT) in 
sedentary, overweight men and 2) to examine the effect of a single bout of exercise on 
resting, fasted HRV and HRV in response to 24-hr post-exercise OGTT.  
4.2 Methods 
 4.2.1 Participants 
 Eight apparently healthy, sedentary, overweight/obese college-aged men gave written 
informed consent to participate in this study.  Individuals who presented with any known 
cardiovascular disease, type 2 diabetes, resting blood pressure !140/90mmHg, and/or body 
mass index !35kg/m2 were excluded.  All participants were physically inactive, non-
smokers, presently not taking any medications, and had physician approval to participate.  





 4.2.2 Experimental Protocol 
 Participants came to the laboratory on six occasions (Figure 4.1).  At the first visit, 
participants performed a maximal cardiorespiratory test (VO2max) on a cycle ergometer 
(Velotron, Racermate, Inc., Seattle, WA).  Participants rode at an initial workload of 25 
Watts for 4-min.  The workload increased by 25 Watts every 4-min until respiratory 
exchange ratio (RER) reached 1.05 after which, the workload increased by 25 Watts every 2-
min until volitional exhaustion.  Lactate was assessed in the final minute of each stage 
(Lactate Plus, Nova Biomedical, USA).  Throughout the test, respiratory gases were analyzed 
using a metabolic cart (ParvoMedics Inc., Sandy, UT) and fat oxidation rates were 
determined using stoichiometric equations15.  
 
 
Figure 4.1. Visit schedule.  *After confirmation of non-diabetic status, participants 
underwent 2 acute exercise sessions in random order.  The intensity of the acute exercise 
sessions were 1) maximal fat oxidation (FM) or 2) 5% below lactate threshold (LT).  A 24-hr 
diet was recorded prior to each PGTT and replicated between sessions. 
 
 On a separate day, the OGTT was performed between 6:00 and 9:00am after 
participants fasted overnight for !10-hr and refrained from exercise for at least 72-hr.  After 
giving a fasting venous blood sample, participants ingested 75 g of glucose to be consumed 
in less than 5-min (Azer Scientific, Morgantown, PA).  Additional blood samples were taken 
!
 81 
at 30, 60, 90 and 120-min during the OGTT.  Plasma glucose levels were determined using a 
standard spectrophotometric assay (Glucose (HK) Assay, Sigma-Aldrich, St. Louis, MO, 
USA).  Respiratory gases were measured 30-min prior to beginning the OGTT and from 30 
to 60-min and 90 to 120-min during the OGTT to determine changes in metabolic rate and 
substrate utilization.  
 Following the VO2max test and baseline OGTT, eight participants underwent two acute 
exercise sessions in a randomized, counterbalanced, cross-over design separated by at least 1 
week.  Five of the eight participants had complete HRV during the baseline and both post-
exercise OGTTs, therefore only five participants were included in subsequent analysis.  
Results from the VO2max test were utilized to determine the following exercise intensities: 1) 
maximal fat oxidation (FM) and 2) high carbohydrate oxidation (5% below lactate threshold; 
LT).  The total dose of exercise was held constant at 400 kcal and the exercise time was 
manipulated in order precisely match the total dose of exercise within an individual.  
Respiratory gases were measured at 5-min intervals prior to 25%, 50%, 75% and 100% of the 
exercise bout, equivalent to 100, 200, 300 and 400kcal, respectively, and the time to 
complete the exercise bout was adjusted accordingly.  Dietary intake was recorded 24-hr 
before the initial OGTT and replicated during the 24-hr period between the exercise session 
and the post-exercise OGTT.  In addition, during the 24-hr period prior to OGTTs, 
participants were asked to refrain from alcohol and caffeine products and avoid physical 






 4.2.3 Heart Rate Variability 
 During the OGTTs and exercise sessions, autonomic function of the heart was 
evaluated using Zephyr heart rate monitor systems (Zephyr Technologies Corp, Maryland, 
USA).  HRV was assessed throughout the 2-hr OGTT, and measured at the time points 5-min 
prior to the start of the OGTT and at 30-35-min, 60-65-min and 115-120-min.  Data were 
stored and later analyzed according to the recommendations of the Task Force of the 
European Society of Cardiology and the North American Society of the Pacing and 
Electrophysiology16.  Time and frequency domain measurements were calculated from 5-min 
epochs after correcting for artifact using a low-pass filter in the HRV analysis software 
(Kubios 2.0, Medical Imaging Group, Kuopio, Finland).  The time domain variables 
considered for this study were the mean RR interval and its standard deviation (RRSD) and 
the mean squared successive difference (RMSSD).  The frequency domains were analyzed 
with an autoregressive model and included very low frequency (VLF: 0-0.04Hz), low 
frequency (LF: 0.04-0.15Hz), high frequency (HF: 0.15-0.4Hz), and LF/HF ratio.  Each 
spectral component was also presented in normalized units (nu) by dividing the LF or HF by 
the total power minus VLF to minimize the VLF component16. 
 4.2.4 Statistical Analysis 
 All statistics were performed using JMP statistical software (SAS Institute Inc., Cary, 
NJ). One way repeated measures analysis of variance (RM-ANOVA) was used to determine 
differences in HRV variables in response to glucose ingestion during the baseline OGTT.  A 
Spearman correlation was run to determine whether glucose was associated with HRV.  In 
addition, a two-way RM-ANOVA (exercise treatment x time) was used to determine 
differences in responses in both the primary outcome variables.  Primary outcomes included 
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time and frequency domains of HRV (mean RR, SDNN, RMSSD, LFnu, HFnu, LF/HF) and 
plasma glucose. Baseline (non-exercise) and exercise (FM and LT combined) comparisons 
were evaluated using contrast statements with the one-way RM-ANOVAs.  Data were 
considered significant of P<0.05 all data are reported as mean ± SD. 
4.3 Results 
 4.3.1 Participants 
Participant characteristics for non-exercise (baseline OGTT completers) and exercise 
subset are presented in Table 4.1.  The eight men (range 18-22y) who participated were 
overweight (BMI 29.5±4.7, 25.2-33.3) and had relatively low cardiorespiratory fitness 
(VO2max 33.2±6.8 mL/kg/min).  Of the eight men participating in baseline testing (VO2max 
and OGTT), only five completed both FM and LT exercise bouts with the post-exercise 
OGTT and HRV measures.  
Table 4.1. Anthropometric and physiological characteristics of participants. 
 




Age  (years) 20.5 ± 1.5 19.8 ± 1.5 
Height  (m) 1.81 ± 0.04 1.80 ± 0.03 
Weight  (kg) 95.9 ± 13.8 87.0 ± 5.5 
BMI  (kg/m2) 29.5 ± 4.7 26.8 ± 1.9 
VO2peak  (mL/kg/min) 33.2 ± 6.8 36.7 ± 6.0 
SBP  (mmHg) 121 ± 9 116 ± 6 
DBP  (mmHg) 71 ± 14 66 ± 5 
Resting HR  (bpm) 71 ± 7 68 ± 5 
Fasting plasma glucose  (mg/dL) 99.5 ± 9.1 95.7 ± 6.6 
Peak plasma glucose  (mg/dL) 147.9 ± 57.1 132.4 ± 46.9 
VO2peak maximal aerobic capacity; SBP systolic blood pressure; DBP diastolic 






 4.3.2 HRV during Baseline (non-exercise) OGTT 
 Fasting blood glucose prior to the baseline OGTT was 99.5±9.1mg/dL, peaked 60-
min after glucose ingestion at 147.9±61.3mg/dL and returned to 115.3±16.5mg/dL at 120-
min post ingestion (0 vs. 60-min, P<0.01; 0 vs. 120-min, P=0.83).  Table 4.2 shows time and 
frequency domain parameters during the baseline (non-exercise) OGTT.  There was no 
change in mean HR or mean RR-interval (P=0.18) over the course of the OGTT.  Normalized 
LF (LFnu) and LF/HF increased 60-min after glucose ingestion (0 vs. 60-min: LFnu 43.4±13.3 
vs. 51.8±11.7, P<0.003; HFnu 57.3±14.2 vs. 48.1±11.7, P<0.007; LF/HF 0.89±0.64 vs. 
1.25±0.84; P<0. 001) and returned to baseline after 120-min (0-min vs. 120-min: LFnu 
43.4±13.3 vs. 44.1±14.4, P=0.62; LF/HF 0.89±0.64 vs. 1.00±0.95; P=0.84).  Normalized HF 
(HFnu) decreased 60-min after glucose ingestion (57.5±14.2 vs. 48.1±11.7; P<0.001) and also 
returned to baseline by 120-min (57.3±14.2 vs. 55.8±14.1, P=0.29).  Higher fasting blood 
glucose (0-min) was associated with reduced HRV (LFnu P<0.009; HFnu P=0.01; LF/HF 
P<0.009).  
Table 4.2.  Time and frequency domain parameters during the baseline (non-exercise) OGTT  
(n=8). 
 
 0min 60min 120min P-ANOVA 
Mean HR  (bpm) 56±9 57±7 58±8 0.18 
Mean RR  (ms) 1102±177 1060±133 1047±145 0.18 
SDNN  (ms) 108±27 108±40 107±33 0.99 
RMSSD  (ms) 109±43 101±50 101±51 0.45 
LFnu 43.4±13.3 51.8±11.7b 44.1±14.4c <0.003 
HFnu 57.3±14.2 48.1±11.7b 55.8±14.1c <0.007 
LF/HF 0.89±0.64 1.25±0.84a 1.00±0.95c <0.01 
aSignificantly different from 0min (P<0.005). bSignificantly different from 0min 





4.3.3 Post-exercise HRV Response during an OGTT: Effect of Different 
Intensities  
Five men performed energy expenditure-matched exercise bouts at FM and LT (FM: 
404.2 ± 7.3kcal vs. LT: 405.5 ± 8.4kcal, P=0.80) although the average exercise intensity was 
different between FM and LT (FM: 41±12%VO2max, 1.25 ± 0.21L/min; LT 68±10%VO2max, 
2.13 ± 0.55L/min; P<0.02).  The average difference between FM and LT exercise intensity 
was 26.8% (range 9.1%-41.0%).  The glucose area under the curve (glucoseAUC) was not 
different between baseline (non-exercise) and LT and FM exercise intensities (Figure 4.2). 
LT exercise decreased HFnu (P<0.01) and increased LFnu (P<0.05) compared to 
baseline (non-exercise) at 0-min.  However, no difference was seen between 24-hr post FM 
exercise compared to baseline (non-exercise) HRV (LFnu P=0.32; HFnu P=0.32).  After 120-
min, both LT and FM exercise had increased LF/HF (0 vs.120-min: LT 0.97±0.33 vs. 
1.12±0.32, FM 0.55±0.32 vs. 1.09±0.22, P<0.01) and LFnu (0 vs.120-min: LT 45.5±5.6 vs. 
52.1±6.9, FM 33.0±11.7 vs. 51.1±5.9, P=0.009) and decreased HFnu (0 vs.120-min: LT 
51.9±8.4 vs. 48.1±7.1, FM 66.9±11.7 vs. 47.7±5.9, P<0.01) compared to baseline (non-
exercise) HRV (Figure 4.3).  
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Figure 4.2.  Glucose area under the curve (GlucoseAUC) per trial.  BL baseline; FM exercise 
Intensity at maximal fat oxidation; LT exercise Intensity at 5% below lactate threshold.  For 
each box-whisker plot, inside line represents median, upper and lower box limits represent 
25th and 75th percentiles, upper and lower bars represent maximum and minimum values, and 




Figure 4.3. Frequency domain HRV parameters over the course of an OGTT per trial.  BL 
baseline; FM exercise Intensity at maximal fat oxidation; LT exercise Intensity at 5% below 
lactate threshold; COM combined exercise trials. For each box-whisker plot, inside line 
represents median, upper and lower box limits represent 25th and 75th percentiles, upper and 
lower bars represent maximum and minimum values, and ! indicates individual responses. * 
Different from baseline (non-exercise) at given time point (P<0.05). ! Different from time 
0min in the given trial (P<0.05). 
! * * 
* * 
* ! ! 
* 
* * * * ! ! 
! ! 
! 





4.3.4 Post-exercise HRV Response during an OGTT: Exercise Intensities 
Combined 
Given exercise intensity had minimal effect on HRV during an OGTT, we further 
examined the effect of an acute bout of exercise by statistically combining the exercise group 
effects.  Fasting blood glucose concentrations at 0-min were not different between baseline 
(non-exercise) and exercise trials combined (baseline 95.7±6.6mg/dL vs. 98.0±7.4mg/dL, 
P=0.24).  At 0-min, LFnu (40.5±12.4 vs. 37.9±5.6, P=0.64), HFnu (59.6±12.2 vs. 62.0±5.6, 
P=0.64) and LF/HF (0.76±0.38 vs. 0.62±0.13, P=0.40) were similar between baseline and 
exercise combined (COM) (Figure 4.3).  At 120-min, a difference was observed between 
exercise combined (COM) and baseline (non-exercise) for LFnu (BL: 37.6±5.3, COM: 
40.5±12.4, P<0.002), HFnu (BL: 62.4±5.3, COM: 59.5±12.4, P<0.002) and LF/HF (BL: 
0.62±0.14, COM: 0.75±0.38, P<0.005).  
4.4 Discussion 
4.4.1 HRV during Baseline (non-exercise) OGTT 
The primary aim of our study was to examine the HRV characteristics during a 
baseline (non-exercise) OGTT and an OGTT 24-hr following a single exercise bout 
performed at FM and LT intensity in overweight, sedentary men.  Our results demonstrated 
that a significant shift from parasympathetic to sympathetic activity occurred during each 
OGTT, suggesting glucose ingestion stimulates an unfavorable shift in autonomic balance 
concordant with increased body mass3,17.  This study supports similar findings seen in 
severely obese individuals3,18-20 and pregnant women21, where sympathetic nervous system 
activity predominates in response to glucose ingestion.  The HFnu component of HRV, 
reflecting parasympathetic neural control, decreased during the baseline OGTT while LFnu, 
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reflecting parasympathetic and sympathetic control demonstrated the opposite effect. 
Sympathovagal balance, measured by LF/HF, also shifted toward sympathetic activity.  The 
mechanism behind increased sympathetic activity in response to glucose ingestion may be a 
consequence of insulin resistance and/or chronic hyperinsulinemia desensitizing the 
sinoatrial node3,20.  Such chronic sympathetic activity may impede parasympathetic 
stimulation of insulin secretion leading to insulin resistance over time22.  
4.4.2 Post-exercise HRV Response during an OGTT: Effect of Different 
Intensities  
Our study demonstrated no significant difference in HRV 24-hr post FM exercise 
prior to the start of the OGTT (0-min).  However, LT exercise prior to the start of the OGTT 
produced a shift in LFnu, HFnu and LF/HF.  A single bout of exercise at low intensity (FM) 
may not be sufficient to impact HRV 24-hr later.  Few studies have examined HRV after 24-
hr of recovery and/or utilized more than one exercise intensity23,24.  James et al. (2012) 
suggested greater exercise intensity initially increases sympathetic activity after exercise, but 
ultimately parasympathetic activity prevailed 24-hr after exercise demonstrating a 
cardioprotective influence23.  However, James et al. used healthy, fit adults, which may 
account for a more rapid return to parasympathetic dominance following high intensity 
exercise, whereas our study examined overweight, sedentary individuals.  Interestingly, the 
shift toward sympathetic dominance before and after exercise may suggest the health of the 
participants (overweight and sedentary) is contributing to poorer HRV indices.  Paolisso et 
al. (1997) found the magnitude of increase in sympathetic activity due to glucose ingestion 
was associated with increasing body fat4.  Future studies should include various 
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cardiovascular risk populations and time course of HRV to determine if exercise intensity has 
a prolonged effect on HRV. 
 At the end of both the FM and LT post-exercise OGTT, LFnu and LF/HF were 
significantly elevated and LFnu significantly depressed compared to the baseline; HRV 
remained shifted toward sympathetic function, suggesting acute exercise does not improve 
the HRV response to glucose ingestion.  A potential explanation for these findings is that 
autonomic imbalance drives an increased secretion of insulin from pancreatic B cells25.  
Sympathetic nerves release noradrenaline to excite pancreatic alpha cells resulting in 
increased glucagon secretion.  The feedback to maintain glucose homeostasis is to increase 
insulin secretion from pancreatic beta cells25.  Acute exercise may perpetuate over-
production of insulin and continue sympathetic dominance in response to glucose ingestion.  
However, the time course for improved insulin sensitivity, or pancreatic beta cell function, 
after acute exercise is unknown. 
 4.4.3 Post-exercise HRV Response during an OGTT: Exercise Intensities 
Combined 
 Regardless of exercise intensity, HRV after exercise was not different from baseline 
(non-exercise) prior to the start of the OGTT (0-min) (Figure 4.3).  Although, single bouts of 
exercise have been found to improve glucose control and insulin sensitivity 11,12, in this study 
no changes in glucoseAUC (Figure 4.2) or HRV (Figure 4.3) were seen, suggesting that acute 
exercise is not sufficient to produce significant improvements in HRV.  Other studies have 
also observed no differences or a return to baseline in HRV 24-hr after exercise24,26.  Studies 
of chronic exercise training have been shown to improve HRV6,7 suggesting chronic exercise 
may be necessary to elicit changes in HRV. 
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In this study, autonomic balance was assessed with only HRV spectral analysis at 
intervals during the OGTTs, which limits the inferences that can be made on the response of 
HRV to glucose ingestion.  A larger sample size and lean control group would help confirm 
the changes in HRV seen in overweight men and also demonstrate whether this population 
continues to have depressed autonomic nervous system function at rest and after acute 
exercise during glucose ingestion.  In addition, the insulin measurement would provide more 
insight to the mechanism behind altered HRV during glucose ingestion.  Despite these 
limitations, this study demonstrated meaningful alterations in HRV after exercise and glucose 
ingestion.  Future studies should include time course information on HRV to examine 
potential prolonged effects of glucose ingestion and exercise at different intensities. 
In conclusion, this study demonstrated that glucose ingestion alters HRV in 
sedentary, overweight men.  Higher exercise intensity shifted HRV 24-hr post-exercise to 
higher sympathetic activity.  This study is the first to report that both FM and LT exercise 
intensity, reflecting low and high exercise intensities, respectively, produce a negative 
change in HRV response to an OGTT.  These findings may have future implications for 
understanding the impact that acute exercise intensity has on HRV during glucose ingestion 
and the importance of exercise as a marker of autonomic balance. 
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CHAPTER 5. IMPACT OF PROGRESSIVE, CHRONIC DEHYDRATION ON 




 Dehydration and heat stress are dual challenges to the cardiovascular system during 
exercise.  The combination of heat stress and dehydration may have concomitant and additive 
consequences on cardiovascular function and sweat responses1,2.  Previous research has 
demonstrated that dehydration impacts physiologic function and performance with as little as 
2% deficit in body water2-4.  Increased core temperature and the subsequent reduced skin 
blood flow limit the capacity to perform exercise due to the increased demand for adequate 
sweat rate and dissipation of heat through the skin5,6.  When the marked cardiovascular 
adjustments that occur during exercise are compromised, thermal regulation may suffer.  In 
addition, prior impaired cardiovascular and nervous control may further hinder thermal 
regulation and skin blood flow during exercise in a heated environment7,8. 
 Evidence suggests individuals only replace ~70% of total water loss during exercise 
in the heat9; individuals do not ingest sufficient fluid during physical activity to replace water 
losses and return to a euhydrated state.  Therefore, individuals may be persistently 
dehydrated day to day, causing impairments in cardiovascular performance and function 
including increased heart rate and blood pressure2,5.  Few studies have examined the effects 
of progressive, chronic dehydration or the long-term health outcomes due to chronic under-
consumption of fluids10.  Therefore, the primary aim of this study is to determine whether 
chronic dehydration, achieved by fluid restriction over a 3-day period, alters cardiovascular 
function and sweat responses during exercise in a heated environment.  In addition, this study 
determined if an individual’s resting cardiovascular health influences their cardiovascular, 
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blood flow, and sweat responses to exercise in a heated environment.  We hypothesized that 
cardiovascular function and sweat response will be preserved in the euhydrated state and 
impaired in a hypohydrated state during exercise in a heated environment due to less 
cardiovascular strain and heat stress during exercise.  We expect that the euhydrated state 
will allow for a lower heart rate, and greater skin blood flow, sweat rate, and temperature 
regulation during exercise compared with the hypohydrated state.  Lastly, we expect resting 
cardiovascular profiles, evaluated by pulse wave velocity (PWV), brachial artery flow-
mediated dilation (BAFMD), and heart rate variability (HRV), would be associated with 
cardiovascular function and sweat responses pending their hydration status. 
5.2 Methods 
 5.2.1 Participants 
 Eighteen participants (6 male, 12 female) aged 20.6±1.2y) participated in this study. 
High-risk individuals as categorized by the American College of Sports Medicine (ACSM), 
including those with known cardiovascular, pulmonary or metabolic disease, or 
sings/symptoms suggestive of disease were excluded11. In addition, participants taking any 
medications that potentially influence fluid balance or cardiovascular function. This study 
was approved by the Louisiana State’s University’s Institutional Review Board. All 
participants provided written informed consent. 
 5.2.2 Experimental Design 
 A counterbalanced, cross-over design was used where participants were randomized 
to two intervention periods and a total of 5 laboratory visits (Figure 5.1).  Following an initial 
screening, participants underwent baseline and cardiovascular testing.  Participants spent 4 
days tracking daily urine color and thirst, which consisted of normal behaviors of food and 
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fluid intake (tracking) (Figure 5.1).  The randomly assigned intervention period was 3 days of 
either hydration (HYD) or dehydration (DEH) where participants were encouraged to drink 
or restrict fluids to achieve each state (intervention).  On the fourth day of the intervention 
period, participants performed exercise testing standardized to the same time of day to reduce 
effects of diurnal variation.  The exercise tests were separated by at least 1 week.  To reduce 
the impact of menstrual cycle on hydration status, female participants performed laboratory 
visits within the first two weeks after the end of their last menstrual cycle. 
5.2.3 Experimental Protocol 
Participants arrived between 8:00-10:00am for the initial screening visit and baseline 
testing after an overnight fast of !10 hours.  In addition, participants were asked to avoid 
alcohol and exercise for at least 48 hours prior to the screening visit (Figure 5.1).  If 
participants signed the informed consent, they proceeded to anthropometrics, resting vitals, 
fasting blood and urine samples, and cardiovascular assessments. 
Figure 5.1. Schedule of study visits.  Tracking periods include normal participant behavior 
for daily fluid and food intake.  Hydration and dehydration interventions were randomized 
and counter-balanced with an exercise test following each period. 
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 Each tracking periods consisted of the 4 days that occurred immediately prior to the 
intervention periods.  During the tracking periods, participants were instructed to follow 
normal food and fluid intake behaviors and record their perceptions of urine color and 
thirst12. During the intervention periods, participants continued to record food and fluid 
intake, perceived urine color, and thirst.  Participants were encouraged not to exercise 
strenuously and to avoid alcohol and prolonged outdoor activities.  However, given the effect 
of caffeine withdrawal on cardiovascular parameters13, and the lack of data to support that 
caffeine promotes dehydration14, normal intake of caffeinated beverages was allowed. At the 
start of the intervention period a fasting blood and urine sample was provided.  The hydration 
status intervention procedures are described as: 
 HYD Trial:  Participants were asked to drink adequate fluids prior to the exercise test 
in order to promote proper hydration indicated by perceived urine color (<3 out of 8) and 
thirst (<3 out of 10).  The U.S. military currently recommends this method to estimate 
hydration status has used this method and has been extensively researched in active 
military12.  
 DEH Trial:  Participants were asked to dehydrate by restricting fluid intake to 
achieve a given thirst level (perceived thirst of 7 out of 10) and urine color (>4 out of 8).  If a 
participant’s thirst exceeded a rating of 7, they were instructed to drink just enough fluids to 
alleviate the sensation of thirst.  In addition, participant’s fluid intake during meals was 
restricted to 1 cup (250mL) of fluid and complete fluid restriction night before the exercise 
test to produce ~2% decrease in body weight. 
 Each exercise test consisted of a 30-min steady-state bout of exercise on a cycle 
ergometer in a heated environment (30.2±0.8°C, 26.5±7.4%RH).  During the steady-state 
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exercise bout, pedal rate on the cycle ergometer was set to 60 RPM and a resistance factor 
necessary to elicit an individualized estimated metabolic rate of 35.0±0.9W/m2 using ACSM 
cycle equations15.  No fluids were allowed during the exercise tests.  Upon entering the lab 
participants voided, provided a urine sample, and nude body weight was recorded.  A rectal 
thermometer was self-inserted to a depth of 10 cm past the anal sphincter and a heart rate 
monitor affixed.  Lastly, a pre-exercise blood sample was taken.  During the exercise test, 
skin temperatures (Tsk) and blood flow (SkBF) were continuously monitored as well as 
substrate metabolism using a metabolic cart.  Sweat samples from the upper back were used 
to assess local sweat rate (LSR) and electrolyte losses.  At the end of the exercise bout, 
participants provided blood and urine samples and a nude weight.  The post-exercise urine 
sample was provided prior to the post-exercise body weight. 
  5.2.4 Experimental Measurements 
  5.2.4.1 Anthropometrics and Cardiovascular Measures 
 Anthropometric measures included height, weight and estimation of body surface 
area using standard equations16.  Body weight was measured to determine changes incurred 
by changing hydration status.  Cardiovascular testing included heart rate variability (HRV), 
pulse wave velocity (PWV) and brachial artery flow-mediated dilation (BAFMD). 
 HRV was examined according to the Task Force for Pacing and Electrophysiology17.  
Briefly, a heart rate monitor (Zephyr Technology Corp., Annapolis, MD) was worn during 
the resting and exercise visits to capture R-R intervals and was analyzed using Kubios 
software 2.0 (Biosignal Analysis and Medical Imaging Group, Kuopio, Finland).  Frequency 
components of HRV included LF and HF expressed in normalized units (nu), calculated by 
dividing the LF and HHF by the total spectral power minus the VLF, and low to high 
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frequency ratio (LF/HF).  Time domain measures included standard deviation of the NN 
intervals (SDNN) and the square root of the mean squared difference of NNs (RMSSD). 
 Vascular function was assessed by BAFMD following current guidelines18.  With 
participants in the supine position and a 3-lead ECG placed on the wrists and leg to monitor 
cardiac cycle, BAFMD will be induced by 5-min of forearm occlusion by inflation of a 
pneumatic cuff (Hokanson) to 200 mmHg, positioned approximately 1 cm distal to the 
olecranon process.  Using ultrasonography (Logiq e Ultrasound, GE Healthcare, WI), the 
brachial artery was imaged for 30 seconds prior to cuff release and for 3-min following 
return to normal, unrestricted blood flow.  BAFMD was calculated as the percent change in 
brachial artery diameter.  All ultrasound images were stored for subsequent analysis (ImageJ 
software, National Institutes of Health).  
 Blood pressures (systolic, diastolic, mean and pulse pressure) and systemic arterial 
stiffness (augmentation pressure and index) were measured with applanation tonometry 
(SphygomoCor, Version 8.0, AtCor Medical). Augmentation index (Aix) was calculated by 
the difference in the second systolic peak and diastolic pressure divided by the difference 
between the first systolic peak and diastolic pressure (x100%)19. 
   5.2.4.2 Blood and Urine Sampling 
 A 5ml venous blood sample was drawn into lithium-heparin tubes.  Whole blood was 
immediately analyzed for contents of hemoglobin spectrophotometrically using the 
cyanmethemoglobin method (Sigma-Aldrich, MO) and hematocrit using the microcapillary 
technique in triplicates. Thereafter, blood was centrifuged and analyzed in triplicates for 
plasma electrolytes, including sodium (Na+), potassium (K+), and chloride (Cl-), and plasma 
osmolality (Posm) using a vapor pressure osmometer (Wescor Elitech Group, Logan, Utah).  
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Urine samples were analyzed for color, urine specific gravity (USG) (hand refractometer, 
NSG Precision Cells, Inc., Farmingdale, NY, USA), urine electrolytes and osmolality 
(Uosm).  Perceived thirst and urine color were recorded on logs using a thirst scale (1 not 
thirsty at all, 10 very, very thirsty) and a urine color scale12.     
5.2.4.3 Skin Temperature and Blood Flow 
Skin thermometers (Biopac Systems, Santa Barbara, CA) were placed on 4 sites: the 
mid-thigh, chest, mid-biceps and calf20.  Weighted skin temperature (Tsk) was estimated 
using the equation of Ramanathan (1964)21.  Total body temperature (Tb) was calculated 
from rectal (Tre) and Tsk22 and then used to calculate the rate of heat storage (HS) using 
previously published equations23.  The change of Tsk was calculated by the difference in skin 
temperatures at that start of exercise (T0) and maximal Tsk (Tmax).  SkBF was measured in 
perfusion units continuously during exercise using a laser Doppler flowmeter (Perimed, 
Stockholm, Sweden).  The laser Doppler probe was affixed to the flexor aspects of the 
forearm (muscle belly of the brachioradialis) using adhesive and surgical tape.  SkBF slope 
was determined by the difference between perfusion units at the onset of SkBF rise and the 
plateau of perfusion units, divided by the time. 
5.2.4.4 Sweat Response and Substrate Metabolism 
During exercise, local sweat rates (LSR) of the upper back were measured during 
exercise with the technical absorbent technique24.  LSR is reported as the difference in pre 
and post patch weight, divided by the surface area (cm2) and duration of application (30-min) 
(mg/cm2*min)24. Sweat collected from the electrolyte-free absorbent patch was centrifuged 
and analyzed for electrolyte concentrations using ion selective electrodes (EasyLyte, Medica 
Corp., MA).  Respiratory gases were monitored during exercise sessions using an integrated 
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oxygen/carbon dioxide analyzer calibrated with standard gas mixtures (TruOne 2400, 
ParvoMedics, Inc., Sandy, UT). 
 5.2.5 Statistical Analysis 
 Statistics were performed in JMP statistical software 12 (SAS Institute Inc., Cary, 
NC).  One-way and two-way (trial by time) repeated measures analysis of variance 
(ANOVA) were performed to determine differences between HYD and DEH and across the 
tracking, intervention, and exercise time points. Significant main or interaction effects were 
further evaluated using Student’s t analyses where appropriate.  Linear and multiple 
regressions were used to determine relationships between resting cardiovascular measures 
and changes in Tsk, SkBF and heat storage by trial before and after adjusting for weight, 
exercise heart rate and VO2, and gender.  Data are displayed as mean ± standard deviation 
and significant differences declared at P<0.05.  
5.3 Results 
 5.3.1 Participants 
 Participant screening characteristics are displayed in Table 5.1. Participants (n=18, 6 
male, 12 female) were normal body weight (67.0±10.6kg, body mass index [BMI] 
23.6±3.4kg/m2) and had a normal systolic (109±9 mmHg) and diastolic (72±7 mmHg) blood 
pressure.  Males were larger than females (body surface area [BSA] 1.92±0.08 vs. 
1.69±0.12m2).  Resting cardiovascular function was assessed by HRV, PWV and BAFMD 
and represented in Table 5.2.  According to previously published research, participants had 





Table 5.1. Screening participant characteristics. 
 
 Male (n=6) Female (n=12) All (n=18) 
Age (y) 20.3±1.9 (19-24) 20.8±0.8 (19-22) 20.6±1.2 
Height (m) 1.74±0.07 (1.68-1.86) 1.66±0.09 (1.56-1.85)* 1.68±0.09 
Weight (kg) 77.8±7.9 (62.9-84.8) 61.6±7.2 (76.9-53.3)* 67.0±10.6 
BMI (kg/m2) 25.4±3.2 (25.7-30.1) 22.5±2.6 (18.9-28.7)* 23.6±3.4 
BSA (m2) 1.92±0.08 (1.79-2.04) 1.69±0.12 (1.54-2.02)* 1.76±0.16 
Systolic BP 108±9 (96-122) 109±9 (90-122) 109±9 
Diastolic BP 71±10 (58-80) 73±5 (62-80) 72±7 
BMI body mass index; BSA body surface area; BP blood pressure. Mean ± standard deviation 
(range). *Different from men (P<0.05). 
 
 
Table 5.2. Screening cardiovascular measures. 
 
Heart Rate Variability 
Resting HR (bpm) 64 ± 8 (44-74) 
Mean RR (ms) 972.2 ± 132.2 (830.8-1374.8) 
SDNN (ms) 102.9 ± 52.5 (31.6-252.7) 
RMSSD (ms) 88.8 ± 47.4 (30.5-172.9) 
LFnu 49.1 ± 13.7 (23.0-74.5) 
HFnu  50.9 ± 13.7 (25.5-77) 
LF/HF 1.13 ± 0.70 (0.30-2.92) 
Vascular Measures 
Aortic Systolic BP (mmHg) 92 ± 7 (81-107) 
Aortic Diastolic BP (mmHg) 71 ± 7 (60-84) 
Mean Arterial Pressure (mmHg) 80 ± 6 (70-94) 
AP (mmHg) 0.1 ± 3.7 (-10.5-7) 
AIx (%) 2.9 ± 11.8 (-18.5-32) 
PWV (m/s) 6.88 ± 1.19 (4.4-9.2) 
Resting artery diameter (mm) 3.54±0.68 (2.51-5.01) 
Peak artery diameter (mm) 3.79±0.71 (2.70-5.25) 
Absolute change (mm) 0.24±0.08 (0.11±0.39) 
BAFMD (%) 6.67±2.33 (2.92-11.16) 
HR heart rate; RR R-to-R interval; SDNN standard deviation of RR intervals; HFnu high 
frequency normalized units; LFnu low frequency normalized units; LF/HF low-to-high 
frequency ratio; BP blood pressure; AP augmentation pressure; AIx augmentation index; 







 5.3.2 Screening and Pre-intervention Visits 
 Weight changes, urine markers and blood markers are displayed in Table 5.3.  No 
difference was observed between tracking period and the start of both HYD and DEH 
intervention periods in perceived urine color (P=0.89) or perceived thirst (P=0.14).  Over the 
course of the tracking periods, weight (P=0.87), USG (P=0.50) and Posm (P=0.13) did not 
change.  Urine color decreased during the tracking period prior to HYD intervention period 
(Screening vs. Pre-HYD intervention, 4±1 vs. 3±1, P<0.05) where as the DEH trial was not 
different from screening (Screening vs. Pre-DEH intervention, 4±1 vs. 4±1, P=0.59). Plasma 
potassium decreased during the tracking period prior to DEH intervention period, but prior to 
HYD intervention period (Screening vs. Pre-DEH intervention, 3.9±0.4 vs. 3.8±0.3, P<0.05; 
Screening vs. Pre-HYD intervention, 3.9±0.4 vs. 3.9±0.2, P=0.23).  The intervention periods 
produced a 0.2±1.0% (range: -1.5-2.3%) increase in body weight during the HYD trial 
compared to -1.0±1.4% (range: -4.0-0.6%) in the DEH trial (pre-intervention to pre-exercise 
body weight).   
 During the randomized intervention periods, two female participants did not follow 
hydration status guidelines of fluid intake to achieve either a HYD or DEH state.  To confirm 
their hydration status was different from the assigned hydration intervention, weight, urine 
and blood markers were measured at the pre-exercise visit.  After confirmation, the two 















Weight (kg) 66.9 ± 10.6 66.9 ± 10.7 66.9 ± 10.7 0.87 
Perceived Thirst 3 ± 1 3 ± 1 3 ± 1 0.14 
Perceived Urine Color 3 ± 2 3 ± 1 4 ± 1 0.89 
Urine Markers 
  Urine Color 4 ± 1 3 ± 1* 4 ± 1 0.13 
  USG 1.019 ± 0.007 1.020 ± 0.005 1.019 ± 0.007 0.50 
  Urine Osm (mOsm/kg) 423.4 ± 376.0 583.2 ± 387.9 465.1 ± 412.7 0.28 
  Urine [Na+] (mmol/l) 127.7 ± 65.3 128.5 ± 57.5 120.6 ± 64.2 0.86 
  Urine [Cl-] (mmol/l) 133.9 ± 65.8 153.2 ± 65.0 131.9 ± 76.8 0.37 
  Urine [K+] (mmol/l) 57.8 ± 46.2 73.9 ± 44.6 63.4 ± 52.8 0.42 
Blood Markers 
  Plasma Osm (mOsm/kg) 292.2 ± 11.8 288.4 ± 11.7 293.0 ± 9.8 0.15 
  Plasma [Na+] (mmol/l) 141.8 ± 1.8 141.8 ± 1.8 140.5 ± 4.6 0.73 
  Plasma [Cl-] (mmol/l) 103.8 ± 2.3 102.2 ± 12.5 103.8 ± 2.1 0.77 
  Plasma [K+] (mmol/l) 3.9 ± 0.4 3.9 ± 0.2 3.8 ± 0.3* 0.02 
  Hematocrit (%) 48 ± 5 47 ± 5 47 ± 4 0.33 
  Hemoglobin (g/dL) 17.2 ± 3.3 15.9 ± 2.2* 15.4 ± 2.7* 0.02 
USG urine specific gravity; Osm osmolality. *Different from baseline P<0.05. 
5.3.4 Pre- and Post-Exercise Visits 
5.3.4.1 Exercise Trials 
Participants’ wattage for workload during the exercise trials was 35.0±0.9W/m2 
(1.1±0.1Kp).  Oxygen consumption (HYD vs. DEH: VO2 1.15±0.26L/min vs. 
1.14±0.16L/min; P=0.84) and respiratory exchange ratio (RER) (HYD vs. DEH: RER 
0.89±0.04 vs. 0.87±0.05; P=0.20) were similar between exercise trials.  Ambient temperature 
(HYD vs. DEH, 30.1±0.9°C vs. 30.4±0.8°C, P=0.37) and relative humidity (HYD vs. DEH, 
27.4±7.4°C vs. 25.6±7.6%, P=0.20) were also not different between exercise trials.  Heart 
rate after 10-min of exercise was not different between trials, but after 20-min and at 30-min 
heart rate was greater in the DEH trial compared to the HYD trial (20-min: 150±27 vs. 
142±23bpm, P=0.02; 30-min: 153±26 vs. 144±23bpm, P=0.02, resp.). 
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5.3.4.2 Blood and Urine Markers 
Table 5.4 represents weight, urine and blood markers from the start of the 
intervention period (Pre-intervention) to the start and end of exercise (Pre- and Post-exercise) 
for 16 participants (6 male, 10 female).  Over the course of the DEH intervention (Pre-
intervention vs. Pre-exercise), weight decreased (67.9±11.0 vs. 66.2±10.8kg, P<0.001), urine 
color increased (4±1 vs. 5±2, P=0.01), and Posm increased (294.4±9.7 vs. 
299.2±8.5mOsm/kg, P=0.03).  The HYD intervention (Pre-intervention vs. Pre-exercise), 
weight (67.7±11.1 vs. 67.8±10.5kg, P=0.88), urine color (3±1 vs. 3±1, P=0.59), and Posm 
(289.8.4±11.6 vs. 290.6±10.5mOsm/kg, P=0.16) were not different from pre-intervention. 
At the start of exercise (Pre-exercise), significant differences between HYD and DEH 
trials were seen in weight (68.8±10.5 vs. 66.2±10.8kg, P<0.005), USG (1.016±0.008 vs. 
1.023±0.007, P<0.001), urine color (3±1 vs. 5±2, P<0.001) and perceived thirst (3±1 vs. 5±1, 
P<0.001).  Posm was also different between trials prior to exercise (HYD vs. DEH, 
282.2±10.5 vs. 301.3±7.6mOsm/kg, P<0.002). 
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USG urine specific gravity; Uosm urine osmolality. Mean ± standard deviation, ! change (95% confidence interval). *Different form 
baseline P<0.05. +Different from pre- to post-exercise (P<0.05). bDifferent between pre-exercise trials (P<0.05). cDifferent between 








! -0.01 (-0.015- -0.005) 
4±1c 
! -1 (-1.8- -0.2) 
247.3±341.3* 
! -125.3 (-340.3-89.7) 
144.0±60.3*c+ 
! -57.2 (-86.0- -28.3) 
188.1±76.0*c 
! -79.4 (-131.8- -26.9) 
103.6±56.5* 


















! -0.009 (-0.013- -0.005) 
5±2*b 
! -2 (-2.9- -1.0) 
223.2±273.3* 
! -100.4 (-318.8-117.9) 
165.1±74.2*b 
! -43.2 (-89.5-3.1) 
192.9±76.7*b 
! -48.7 (-97.4-0.0) 
91.0±59.9 


















! 0.002 (-0.001-0.006) 
4±1 
! -0.4 (-1.1-0.4) 
512.3±414.3 
! 135.2 (-116.3-386.7) 
120.6±67.1 
! 10.5 (-22.5-43.5) 
133.8±78.7 
! 24.8 (-19.5-69.2) 
68.1±54.3 
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Posm plasma osmolality; Hb hemoglobin. Mean ± standard deviation, ! change (95% confidence interval). *Different form baseline 





! -4.0 (-11.9-3.8) 
142.9±2.7 
! -0.1 (-2.2-1.6) 
105.9±6.5*c 
! -3.4 (-8.3-1.6) 
4.16±0.52*+ 
! -0.11 (-0.47-0.26) 
46±3c 
! 3.2 (-0.1-6.5) 
16.1±3.2 











! -11.2 (-19.0- -3.3) 
142.9±2.0b 
! -1.3 (-2.3- -0.2) 
106.3±6.2 
! -1.5 (-3.4-0.5) 
4.03±0.59 
! -0.13 (-0.49-0.22) 
46±4 
! 2.9 (-0.8-6.7) 
16.4±3.3 











! -4.6 (-9.41-0.16) 
141.6±1.6 
! 0.3 (-0.7-1.3) 
103.7±2.0 
! 1.1 (-1.5-3.6) 
3.79±0.30 
! 0.13 (-0.00-0.26) 
47±4 
! 0.5 (-1.7-2.8) 
15.7±2.7 








  Posm (mOsm/kg) 
  Plasma [Na+] (mmol/L) 
  Plasma [Cl-] (mmol/L) 
  Plasma [K+] (mmol/L) 
  Hematocrit (%) 




 5.3.5 Tsk, SkBF and Sweat Responses to Exercise and Relationships to 
Cardiovascular Function 
 Tsk, SkBF (n=12) and LSR (n=10) measurements are displayed in Table 5.5.  
Complete Tsk data was determined in 12 participants, and sweat electrolytes were assessed in 
10 participants (5 male, 5 female); 6 participants did not produce enough sweat to measure 
electrolytes.  LSR was not different between exercise trials (HYD vs. DEH, 4.4±3.3 vs. 
4.3±3.7g/cm2/min).  Tsk after 30-min of exercise was not different between HYD and DEH 
trials (Tsk P=0.47, Tb P=0.72).  There were also no observed differences between HYD and 
DEH temperature change at Tsk or Tb (Figure 5.2).  Mean HS was higher in the DEH trial 
compared to the HYD trial (48.3±31.9 vs. 45.9±25.4, P=0.73), but the peak HS was higher in 
the HYD trial compared to the DEH trial (189.5±65.8 vs. 150.9±67.8, P=0.09).  SkBF tended 
to be greater in the HYD trial compared to the DEH trial (SkBF slope: HYD vs. DEH, 
3.5±2.6 vs. 2.4±1.1, P=0.05; SkBF Change: HYD vs. DEH, 370.0±156.3 vs. 169.0±130.4%, 












Table 5.5. Tsk, SkBF (n=12) and sweat (n=10) responses to exercise. 
 
 HYD DH ANOVA  
(P value) 
Skin Temperatures 
  Mean HS (W/m2) 45.9 ± 25.4 48.3 ± 31.9 0.73 
  Peak HS (W/m2) 189.5 ± 65.8 150.9 ± 67.8 0.09 
  Tsk        
T0 32.2 ± 0.7 32.6 ± 0.5  
Tmax 33.7 ± 0.9 33.8 ± 0.9  
Change 1.49 ± 0.59 1.29 ± 0.85 0.23 
  Tb        
T0 36.5 ± 3.5 36.2 ± 2.5  
Tmax 37.0 ± 3.4 36.3 ± 0.37  
Change 0.61 ± 0.31 0.65 ± 0.46 0.65 
Skin Blood Flow 
  SkBF Start (PU) 8.0 ± 2.9 9.5 ± 3.5 0.17 
  SkBF End (PU) 38.3 ± 22.6 32.2 ± 8.5 0.25 
  SkBF Slope 3.5 ± 2.6 2.4 ± 1.1 0.05 
  SkBF Change (%) 370.0 ± 156.3 169.0 ± 130.4 0.05 
Sweat Response 
  LSR (g/cm2/min) 4.4 ± 3.3 4.3 ± 3.7 0.93 
  Sweat [Na+] (mmol/L) 56.3 ± 28.7 59.9 ± 26.1 0.71 
  Sweat [Cl-] (mmol/L) 56.2 ± 28.5 54.7 ± 30.5 0.86 
  Sweat [K+] (mmol/L) 7.6 ± 3.0 7.9 ± 4.1 0.97 
HS heat storage; Tsk weighted skin temperature; Tb body temperature; T0 
temperature at time zero; Tmax temperature peak; LSR local sweat rate. 
 
 After collapsing the exercise trials together (n=24), a linear regression showed an 
increase in BAFMD was related to an increase change in Tsk (P=0.04) and Tb (P=0.006) 
during exercise.  Increased LF/HF was related to increased peak heat storage (P=0.03).  
Lastly, no relationships between SkBF, LSR and the resting cardiovascular measures were 




Figure 5.2. Weighted skin temperature (Tsk), rectal temperature, total body temperature (Tb) and 2-min average heat storage (HS) 





  This study demonstrated that 3 days of chronic, progressive dehydration altered 
weight, urine and blood markers of hydration, and altered cardiovascular response to exercise 
in a heated environment.  In addition, BAFMD was related to the change in weighted skin 
temperature and body temperature during exercise in the heat, suggesting resting vascular 
function plays a role in the rate in which body temperature increases.  Increased LF/HF at 
rest was associated with increased peak heat storage, suggesting greater sympathetic tone at 
rest leads to a greater rate in which heat is stored during exercise.  Together these results 
suggest that chronic, progressive dehydration can produce significant alterations in hydration 
markers and cardiovascular responses to exercise in the heat may be influenced by resting 
cardiovascular health. 
 From screening through the tracking periods, participants maintained the same 
hydration status as measured by weight, perceived thirst and urine color, and urine specific 
gravity suggesting participants started hydration interventions in similar states (Table 5.2).  
Furthermore, the similar states produced pre-intervention suggested that the second 
randomized tracking period was sufficient time to return to screening hydration status.  
Although urine color pre-HYD intervention was significantly different from screening, this 
measure is subjective and may not represent a meaningful change.   
 According to current recommendations, the combination of weight, urine color and 
thirst provide a strong indication of a hypohydrated state11,28.  During the HYD and DEH 
interventions, participants achieved a small change in body weight (HYD trial 0.2±1.0% vs. 
DEH trial -1.0±1.4%).  In comparison, the majority of studies involving dehydration achieve 
a decrease of 3% in body weight1,3.  Despite these small changes, perceived thirst, weight and 
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urine color were different between pre-HYD and pre-DEH trials, suggesting participants 
achieved a euhydrated and hypohydrated state, respectively.  In addition, plasma osmolality 
and urine specific gravity were also different between pre-HYD and pre-DEH trials, 
suggesting participants were in a dehydrated state.  
 The exercise bouts for both HYD and DEH trials were performed in similar 
environments (30.2±0.8°C, 26.5±7.4%RH).  When exercise was performed in the DEH trial, 
heart rate was significantly higher (P=0.02), suggesting a hypohydration is more taxing on 
the cardiovascular system compared to a euhydrated state2.  SkBF (% change) tended to be 
blunted during the DEH trial (Table 5.5).  Dehydration and heat stress have been shown to 
independently and together reduce SkBF and heat dissipation29 and ultimately may impair 
aerobic performance30.  Interestingly, heat storage and body temperature were greater 
initially in the HYD trial compared to the DEH trial (Figure 5.2).  Heat storage and body 
temperature tended to be greater in the DEH trial compared to HYD trial at the end of 30-
min, suggesting thermoregulatory mechanisms are prompted manage heat stress more 
efficiently when euhydrated compared to dehydrated.  However, in this apparently healthy 
population, the environment and work rate may not have produced enough stress on the 
cardiovascular system to significantly alter SkBF and sweat rate.  Previous studies 
demonstrate sweat rate is varies widely depending on exercise intensity and environment31.  
In addition, light clothing was worn during exercise trials in order to permit heat loss, but the 
participants’ fitness level may have impacted their sweat rate.  Those with increased aerobic 
fitness may be more likely to tolerate heat exposure, therefore respond by sweating more32. 
 Increased BAFMD was related to both increased weighted skin temperature and body 
temperature.  With improved resting BAFMD, the vasculature may have greater ability to 
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dilate during exercise in the heat and in turn raise body temperature to a greater degree by 
increasing skin blood flow.  Carter et al. (2014) demonstrated repeated increases in core 
temperature through local heating resulted in increased BAFMD, suggesting 
thermoregulation-mediated changes in blood flow can improve conduit vascular function33.  
Increased cardiovascular function, as measured by BAFMD, may be a useful biomarker in 
the ability to thermoregulate during exercise with heat stress.  In addition, increased 
sympathetic activity, measured by LF/HF, was related to the peak heat storage.  Those with 
poorer autonomic balance may have a more difficult time adapting to exercise in the heat 
while in a dehydrated state due to increasing the rate in which they store heat.  In rats 
subjected to heat stress with and without dehydration, dehydrated rats had increased HF, 
suggesting higher sympathetic activity when dehydrated34. Similarly, Crandall et al. (2000) 
found increased HF and reduced vagal tone when participants were subjected to whole body 
heat stress35.  Competing metabolic and thermoregulatory demands during exercise and heat 
stress may cause the sympathetic innervation of the skin to constrict in order to redirect blood 
flow to the core36.  Therefore, increase the rate in which heat is stored.   
 A limitation of this study was participant compliance with the interventional protocol.  
Hydration and/or dehydration was self-determined, which may have limited the magnitude of 
change in body weight and hydration status.  Yet, blood and urine markers of hydration 
status were influenced with the small changes produced.  This study also delivered a low 
environmental stress and work rate during the exercise bouts compared to current 
literature1,2,7.  In this study, greater differences between HYD and DEH exercise trials may 
have been observed had the bout been longer to pose more stress. 
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 In conclusion, progressive, chronic dehydration produced changes in weight, urine 
and blood markers, and cardiovascular response to exercise in a heated environment.  
Improved vascular cardiovascular function measured by BAFMD may be related to the 
ability to better deliver blood flow to the skin during exercise in the heat; however, resting 
indicators of increased sympathetic activity may be related to increased rate of heat storage 
during exercise.  Future research should continue to examine the impact of resting 
cardiovascular function on cardiovascular and thermoregulatory responses to exercise, 
particularly in a dehydrated state. 
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CHAPTER 6. CONCLUSION 
 The purpose of this dissertation was to study non-invasive markers of cardiovascular 
and autonomic function in response various conditions including exercise, glucose ingestion 
and dehydration.  The meta-analysis (chapter 3) was designed to target the effects of exercise 
training on endothelial function, as measured by BAFMD.  In the 66 studies analyzed (1865 
trained, 635 control), BAFMD proved to be a useful biomarker in detecting changes in 
function resulting from exercise training  (P<0.0001).  Aerobic exercise tended to have the 
greatest effect on BAFMD (ES 9.30; 95%CI, 6.29-12.31).  In addition, greater exercise 
training intensity and volume appeared to play an important role in the magnitude of change 
in BAFMD.  This study sheds light on the impact of exercise training on vascular function 
and may help future studies to better prescribe exercise to improve vascular health in both 
healthy and diseased individuals.  Future studies should implement BAFMD as a useful 
clinical tool to assess vascular function, which is capable of detecting changes in response to 
exercise training. 
 In chapter 4, participants shifted to higher sympathetic activity (increased LFnu and 
LF/HF), suggesting glucose ingestion may increase autonomic dysfunction.  Secondly, a 
single bout of low- or high-intensity exercise altered the autonomic response to an OGTT, 
leading to increased LFnu, LF/HF and decreased HFnu(P<0.01).  This study was unique in that 
autonomic balance, measured by HRV, was assessed in response to and OGTT after two 
different exercise intensities that were set not as an arbitrary relative intensity (%VO2max), but 
according to the intensity relative to each individuals ability to oxidize fat (FM) or work at 
lactate threshold (LT).  Future research should continue to investigate the potential changes 
in HRV after exercise in individuals with chronic exposure to high blood glucose and/or 
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insulin.  Acute exercise and exercise training may produce different alterations in HRV, 
especially depending on a diseased state.  
 Lastly, chapter 5 aimed to determine if resting cardiovascular function influenced 
cardiovascular and sweat response to exercise in the heat when euhydrated and 
hypohydrated.  After the hydration interventions, weight (P<0.005), USG (P<0.001), urine 
color (P<0.001), perceived thirst (P<0.001) and plasma osmolality (P<0.002) were different 
between HYD and DEH trials.  This suggests the interventions produced significantly altered 
hydration statuses.  DEH trials produced elevated heart rate and blood pressure compared to 
the HYD trial, suggesting more cardiovascular strain occurs when in a hypohydrated state.  
BAFMD was associated with increased core temperature (P=0.006) suggesting greater ability 
to dilate vasculature may allow for increased blood flow to the skin.  In addition, increased 
sympathetic activity at rest (increased LF/HF) may impact the rate of heat storage (P=0.03).  
This study was unique in that progressive, chronic dehydration induced changes in blood and 
urine markers, thirst and weight.  Secondly, this study is the first to our knowledge to 
examine the impact of resting cardiovascular function on responses to exercise in the heat in 
young, healthy college-aged participants.  This research may lead to using the cardiovascular 
health profile to predict changes in cardiovascular, thermoregulatory and sweat responses 
during exercise.  Future research should continue to examine the dual impact of heat stress 
and dehydration during exercise on cardiac and sweat responses, particularly in both healthy 
and diseased participants due to the effects health status may have. 
 In summary, cardiovascular and autonomic functions are intertwined systems that are 
alerted depending on health status.  Exercise training may mitigate dysregulation of these 
systems, while glucose ingestion, dehydration and heat stress may complicate their 
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responses.  As cardiovascular health persists as a public health issue, exercise training may 
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